Unnamed: 0.1,Unnamed: 0,Sex,Year of diagnosis,Year of death recode,Months from diagnosis to treatment,RX Summ--Surg Prim Site (2003+),RX Summ--Surg/Rad Seq (2006+),RX Summ--Systemic/Sur Seq (2007+),Reason no cancer-directed surgery (2006+),"Chemotherapy recode (yes, no/unk) (2004+)",Radiation recode (2003+),Breast Subtype (2010+),ER Status Recode Breast Cancer (2010+),PR Status Recode Breast Cancer (2010+),Derived HER2 Recode (2010+),Behavior code ICD-O-3,Behavior recode for analysis,Site recode ICD-O-3 2023 Revision Expanded,Histologic Type ICD-O-3,Grade Recode (thru 2017),Grade Clinical (2018+),Grade Pathological (2018+),ICCC site recode extended 3rd edition/IARC 2017,ICD-O-3 Hist/behav,"ICD-O-3 Hist/behav, malignant",AJCC ID (2018+),Laterality,Combined Summary Stage (2004+),Age recode with single ages and 90+,Total number of in situ/malignant tumors for patient,Total number of benign/borderline tumors for patient,Rural-Urban Continuum Code
26,54,Female,2020,Alive at last contact,000,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended, unknown if performed",No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,2,9,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,76 years,2,0,Counties in metropolitan areas ge 1 million pop
29,57,Female,2020,Alive at last contact,000,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,1,2,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,86 years,2,0,Counties in metropolitan areas ge 1 million pop
31,61,Female,2020,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy both before and after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8520,Unknown,2,9,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
70,133,Female,2020,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy both before and after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,2,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,80 years,2,0,Counties in metropolitan areas ge 1 million pop
80,151,Female,2020,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,72 years,3,0,Counties in metropolitan areas ge 1 million pop
89,174,Female,2020,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,67 years,2,0,Counties in metropolitan areas ge 1 million pop
94,186,Female,2020,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,9,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,73 years,2,0,Counties in metropolitan areas ge 1 million pop
153,295,Female,2020,2020,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended but not performed, patient refused",No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Unknown,2,9,Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,No AJCC Chapter,Right - origin of primary,In situ,87 years,4,0,Counties in metropolitan areas ge 1 million pop
156,302,Female,2020,Alive at last contact,006,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,88 years,3,0,Counties in metropolitan areas ge 1 million pop
158,307,Female,2020,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,2,2,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,71 years,2,0,Counties in metropolitan areas ge 1 million pop
172,347,Female,2020,Alive at last contact,003,45,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,61 years,2,0,Counties in metropolitan areas ge 1 million pop
234,600,Female,2020,Alive at last contact,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,Refused (1988+),HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
235,604,Female,2020,Alive at last contact,001,24,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,73 years,1,0,Counties in metropolitan areas ge 1 million pop
261,692,Male,2020,Alive at last contact,000,41,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,C,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Regional,80 years,6,0,Counties in metropolitan areas ge 1 million pop
276,729,Female,2020,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,55 years,3,0,Counties in metropolitan areas ge 1 million pop
286,748,Female,2020,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Regional,57 years,4,0,Counties in metropolitan areas ge 1 million pop
287,749,Female,2020,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,1,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,57 years,4,0,Counties in metropolitan areas ge 1 million pop
319,841,Female,2020,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,68 years,2,0,Counties in metropolitan areas ge 1 million pop
328,872,Female,2020,Alive at last contact,001,0,No radiation and/or cancer-directed surgery,Systemic therapy before surgery,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,9,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Distant,52 years,2,0,Counties in metropolitan areas ge 1 million pop
359,952,Female,2020,Alive at last contact,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,81 years,2,0,Counties in metropolitan areas ge 1 million pop
376,1004,Female,2020,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Unknown,H,H,Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Breast DCIS,Left - origin of primary,In situ,71 years,3,0,Counties in metropolitan areas ge 1 million pop
405,1082,Female,2020,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,76 years,3,0,Counties in metropolitan areas ge 1 million pop
440,1187,Female,2020,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,Malignant,Malignant,Breast,8520,Unknown,1,9,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,83 years,4,0,Counties in metropolitan areas ge 1 million pop
441,1188,Female,2020,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8575,Unknown,9,2,XIf6 Carcinomas of breast,"8575/3: Metaplastic carcinoma, NOS","8575/3: Metaplastic carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,83 years,4,0,Counties in metropolitan areas ge 1 million pop
472,1273,Female,2020,Alive at last contact,002,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,9,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,70 years,2,0,Counties in metropolitan areas ge 1 million pop
487,1317,Female,2020,Alive at last contact,002,30,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,64 years,1,0,Counties in metropolitan areas ge 1 million pop
543,1479,Female,2020,Alive at last contact,001,24,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,73 years,2,0,Counties in metropolitan areas ge 1 million pop
553,1508,Female,2020,Alive at last contact,000,0,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Not recommended,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,3,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,78 years,2,0,Counties in metropolitan areas ge 1 million pop
556,1517,Female,2020,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,62 years,1,0,Counties in metropolitan areas ge 1 million pop
558,1521,Female,2020,Alive at last contact,003,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,2,9,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,83 years,2,0,Counties in metropolitan areas ge 1 million pop
562,1534,Female,2020,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,66 years,2,0,Counties in metropolitan areas ge 1 million pop
569,1547,Female,2020,Alive at last contact,004,51,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,83 years,2,0,Counties in metropolitan areas ge 1 million pop
570,1549,Female,2020,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,72 years,2,0,Counties in metropolitan areas ge 1 million pop
617,1672,Female,2020,Alive at last contact,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended, unknown if performed",No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Unknown,M,9,Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Breast DCIS,Left - origin of primary,In situ,73 years,3,0,Counties in metropolitan areas ge 1 million pop
650,1762,Female,2020,Alive at last contact,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,66 years,2,0,Counties in metropolitan areas ge 1 million pop
658,1785,Female,2020,Alive at last contact,002,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,2,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,61 years,1,0,Counties in metropolitan areas ge 1 million pop
680,1864,Female,2020,Alive at last contact,000,41,Radiation after surgery,Systemic therapy before surgery,Surgery performed,Yes,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,2,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Regional,71 years,2,0,Counties in metropolitan areas ge 1 million pop
682,1872,Female,2020,Alive at last contact,004,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Unknown,1,2,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,83 years,3,0,Counties in metropolitan areas ge 1 million pop
683,1873,Female,2020,Alive at last contact,001,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8522,Unknown,1,1,XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Breast Invasive,Right - origin of primary,Localized,84 years,3,0,Counties in metropolitan areas ge 1 million pop
710,1940,Female,2020,Alive at last contact,003,40,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,63 years,2,0,Counties in metropolitan areas ge 1 million pop
714,1946,Female,2020,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,85 years,3,0,Counties in metropolitan areas ge 1 million pop
817,2179,Female,2020,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Unknown,9,M,Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Breast DCIS,Left - origin of primary,In situ,69 years,2,0,Counties in metropolitan areas ge 1 million pop
819,2184,Female,2020,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,L,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,58 years,2,0,Counties in metropolitan areas ge 1 million pop
830,2228,Female,2020,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Negative,Borderline/Unknown,Malignant,Malignant,Breast,8500,Unknown,H,H,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,63 years,2,0,Counties in metropolitan areas ge 1 million pop
951,2505,Female,2020,Alive at last contact,003,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Refused (1988+),HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,9,2,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,73 years,2,0,Counties in metropolitan areas ge 1 million pop
959,2520,Female,2020,Alive at last contact,001,20,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,1,2,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,78 years,2,0,Counties in metropolitan areas ge 1 million pop
962,2527,Female,2020,Alive at last contact,001,20,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Refused (1988+),HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,64 years,3,0,Counties in metropolitan areas ge 1 million pop
976,2576,Female,2020,Alive at last contact,004,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,9,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,72 years,2,0,Counties in metropolitan areas ge 1 million pop
984,2598,Female,2020,Alive at last contact,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended but not performed, patient refused",No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,2,9,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
994,2617,Female,2020,Alive at last contact,002,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended, unknown if performed",No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,78 years,3,0,Counties in metropolitan areas ge 1 million pop
995,2618,Female,2020,Alive at last contact,002,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended, unknown if performed",No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,78 years,3,0,Counties in metropolitan areas ge 1 million pop
996,2619,Female,2020,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,60 years,2,0,Counties in metropolitan areas ge 1 million pop
25,53,Female,2019,Alive at last contact,002,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,65 years,2,0,Counties in metropolitan areas ge 1 million pop
33,64,Female,2019,Alive at last contact,000,20,Intraoperative radiation,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Radioactive implants (includes brachytherapy) (1988+),HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,77 years,3,0,Counties in metropolitan areas ge 1 million pop
34,66,Female,2019,Alive at last contact,004,44,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,58 years,4,0,Counties in metropolitan areas ge 1 million pop
35,67,Female,2019,Alive at last contact,004,44,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,58 years,4,0,Counties in metropolitan areas ge 1 million pop
60,112,Female,2019,Alive at last contact,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Unknown,L,9,Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Breast DCIS,Right - origin of primary,In situ,77 years,2,0,Counties in metropolitan areas ge 1 million pop
87,165,Female,2019,Alive at last contact,002,30,No radiation and/or cancer-directed surgery,Systemic therapy both before and after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Unknown,2,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,55 years,2,0,Counties in metropolitan areas ge 1 million pop
93,185,Female,2019,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,M,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,"Bilateral, single primary",Localized,79 years,2,0,Counties in metropolitan areas ge 1 million pop
140,272,Female,2019,Alive at last contact,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended but not performed, patient refused",No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Unknown,1,9,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,86 years,4,0,Counties in metropolitan areas ge 1 million pop
193,422,Female,2019,Alive at last contact,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Unknown,M,9,Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Breast DCIS,Left - origin of primary,In situ,71 years,2,0,Counties in metropolitan areas ge 1 million pop
194,428,Female,2019,Alive at last contact,001,24,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,72 years,4,0,Counties in metropolitan areas ge 1 million pop
199,440,Female,2019,Alive at last contact,002,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Unknown,2,9,Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Breast DCIS,Right - origin of primary,In situ,76 years,3,0,Counties in metropolitan areas ge 1 million pop
206,474,Female,2019,2020,002,20,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,90+ years,4,0,Counties in metropolitan areas ge 1 million pop
219,541,Female,2019,Alive at last contact,002,20,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,2,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,80 years,2,0,Counties in metropolitan areas ge 1 million pop
291,759,Female,2019,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,72 years,2,0,Counties in metropolitan areas ge 1 million pop
309,822,Female,2019,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8520,Unknown,9,9,Not classified by SEER or in situ,8520/2: Lobular carcinoma in situ,In situ,No AJCC Chapter,Left - origin of primary,In situ,81 years,2,0,Counties in metropolitan areas ge 1 million pop
332,877,Female,2019,Alive at last contact,002,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Refused (1988+),HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,1,1,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,77 years,3,0,Counties in metropolitan areas ge 1 million pop
361,958,Female,2019,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,64 years,2,0,Counties in metropolitan areas ge 1 million pop
362,964,Female,2019,Alive at last contact,002,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,88 years,3,0,Counties in metropolitan areas ge 1 million pop
367,979,Female,2019,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,88 years,3,0,Counties in metropolitan areas ge 1 million pop
372,995,Female,2019,Alive at last contact,003,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8140,Unknown,9,9,XIf6 Carcinomas of breast,"8140/3: Adenocarcinoma, NOS","8140/3: Adenocarcinoma, NOS",Breast Invasive,Left - origin of primary,Regional,74 years,2,0,Counties in metropolitan areas ge 1 million pop
412,1109,Female,2019,Alive at last contact,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,Yes,None/Unknown,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Unknown,2,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Distant,82 years,2,0,Counties in metropolitan areas ge 1 million pop
415,1115,Female,2019,2020,002,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,B,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,62 years,4,0,Counties in metropolitan areas ge 1 million pop
416,1116,Female,2019,2020,000,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,A,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,62 years,4,0,Counties in metropolitan areas ge 1 million pop
426,1147,Female,2019,Alive at last contact,006,40,No radiation and/or cancer-directed surgery,Systemic therapy both before and after surgery,Surgery performed,Yes,Refused (1988+),HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,74 years,3,0,Counties in metropolitan areas ge 1 million pop
427,1148,Female,2019,Alive at last contact,006,40,No radiation and/or cancer-directed surgery,Systemic therapy both before and after surgery,Surgery performed,Yes,Refused (1988+),HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Regional,74 years,3,0,Counties in metropolitan areas ge 1 million pop
455,1209,Female,2019,2020,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,Yes,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8530,Unknown,9,9,XIf6 Carcinomas of breast,8530/3: Inflammatory carcinoma,8530/3: Inflammatory carcinoma,Breast Invasive,Left - origin of primary,Distant,73 years,3,0,Counties in metropolitan areas ge 1 million pop
461,1220,Female,2019,Alive at last contact,003,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Regional,71 years,2,0,Counties in metropolitan areas ge 1 million pop
500,1352,Female,2019,Alive at last contact,001,51,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8500,Unknown,H,H,Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Breast DCIS,Right - origin of primary,In situ,65 years,2,0,Counties in metropolitan areas ge 1 million pop
504,1363,Female,2019,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,1,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,75 years,2,0,Counties in metropolitan areas ge 1 million pop
507,1370,Female,2019,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Unknown,2,2,Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Breast DCIS,Left - origin of primary,In situ,80 years,3,0,Counties in metropolitan areas ge 1 million pop
518,1400,Female,2019,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,65 years,2,0,Counties in metropolitan areas ge 1 million pop
528,1432,Female,2019,2020,000,51,Radiation after surgery,Systemic therapy before surgery,Surgery performed,Yes,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8520,Unknown,2,9,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,72 years,3,0,Counties in metropolitan areas ge 1 million pop
550,1497,Female,2019,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Unknown,9,2,Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Breast DCIS,Left - origin of primary,In situ,50 years,2,0,Counties in metropolitan areas ge 1 million pop
551,1498,Female,2019,Alive at last contact,002,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,2,2,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,71 years,2,0,Counties in metropolitan areas ge 1 million pop
571,1554,Female,2019,Alive at last contact,001,30,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,In situ,In situ,Breast,8500,Unknown,H,H,Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Breast DCIS,Right - origin of primary,In situ,68 years,2,1,Counties in metropolitan areas ge 1 million pop
575,1563,Female,2019,Alive at last contact,000,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,2,9,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,90+ years,3,0,Counties in metropolitan areas ge 1 million pop
586,1593,Female,2019,Alive at last contact,002,23,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,67 years,2,0,Counties in metropolitan areas ge 1 million pop
590,1608,Female,2019,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy before surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,3,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,75 years,2,0,Counties in metropolitan areas ge 1 million pop
603,1642,Female,2019,Alive at last contact,002,24,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,88 years,3,0,Counties in metropolitan areas ge 1 million pop
627,1696,Female,2019,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Refused (1988+),HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,72 years,2,0,Counties in metropolitan areas ge 1 million pop
632,1708,Female,2019,Alive at last contact,002,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,3,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Distant,74 years,3,0,Counties in metropolitan areas ge 1 million pop
633,1709,Female,2019,Alive at last contact,001,24,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,70 years,2,0,Counties in metropolitan areas ge 1 million pop
636,1722,Female,2019,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,72 years,1,0,Counties in metropolitan areas ge 1 million pop
644,1742,Female,2019,Alive at last contact,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,H,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,81 years,3,0,Counties in metropolitan areas ge 1 million pop
649,1760,Female,2019,Alive at last contact,002,30,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
661,1800,Female,2019,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,63 years,2,0,Counties in metropolitan areas ge 1 million pop
668,1822,Female,2019,Alive at last contact,000,0,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Not recommended,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Distant,36 years,2,0,Counties in metropolitan areas ge 1 million pop
677,1855,Female,2019,Alive at last contact,Blank(s),22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8500,Unknown,9,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,81 years,4,0,Counties in metropolitan areas ge 1 million pop
693,1897,Female,2019,Alive at last contact,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,75 years,2,0,Counties in metropolitan areas ge 1 million pop
713,1943,Female,2019,Alive at last contact,000,30,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8010,Unknown,2,2,XIf6 Carcinomas of breast,"8010/3: Carcinoma, NOS","8010/3: Carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,69 years,2,0,Counties in metropolitan areas ge 1 million pop
716,1953,Female,2019,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,55 years,3,0,Counties in metropolitan areas ge 1 million pop
720,1958,Female,2019,Alive at last contact,000,63,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,57 years,2,0,Counties in metropolitan areas ge 1 million pop
738,2000,Female,2019,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,B,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,65 years,2,0,Counties in metropolitan areas ge 1 million pop
742,2011,Female,2019,Alive at last contact,003,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended but not performed, patient refused",Yes,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Unknown,3,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,60 years,2,0,Counties in metropolitan areas ge 1 million pop
751,2023,Female,2019,Alive at last contact,000,45,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,62 years,2,0,Counties in metropolitan areas ge 1 million pop
768,2064,Female,2019,Alive at last contact,002,48,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,2,2,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,59 years,3,0,Counties in metropolitan areas ge 1 million pop
799,2133,Female,2019,Alive at last contact,002,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,9,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,75 years,4,0,Counties in metropolitan areas ge 1 million pop
811,2154,Female,2019,2019,000,0,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Unknown,9,9,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Distant,83 years,2,0,Counties in metropolitan areas ge 1 million pop
833,2235,Female,2019,Alive at last contact,002,24,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,9,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,74 years,2,0,Counties in metropolitan areas ge 1 million pop
846,2268,Female,2019,Alive at last contact,001,23,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,Malignant,Malignant,Breast,8520,Unknown,9,1,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,74 years,2,0,Counties in metropolitan areas ge 1 million pop
848,2275,Female,2019,Alive at last contact,001,22,Intraoperative radiation,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,65 years,2,0,Counties in metropolitan areas ge 1 million pop
849,2279,Female,2019,Alive at last contact,002,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,"Recommended, unknown if administered",Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8503,Unknown,1,1,Not classified by SEER or in situ,8503/2: Noninfiltrating intraductal papillary adenocarcinoma,In situ,Breast DCIS,Right - origin of primary,In situ,69 years,3,0,Counties in metropolitan areas ge 1 million pop
856,2301,Female,2019,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,81 years,2,0,Counties in metropolitan areas ge 1 million pop
857,2304,Female,2019,Alive at last contact,001,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Regional,57 years,2,0,Counties in metropolitan areas ge 1 million pop
858,2306,Female,2019,Alive at last contact,003,43,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,79 years,2,0,Counties in metropolitan areas ge 1 million pop
895,2386,Female,2019,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,88 years,3,0,Counties in metropolitan areas ge 1 million pop
896,2387,Female,2019,Alive at last contact,000,51,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Unknown,1,3,XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Breast Invasive,Left - origin of primary,Regional,88 years,3,0,Counties in metropolitan areas ge 1 million pop
897,2388,Female,2019,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Unknown,M,M,Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Breast DCIS,Right - origin of primary,In situ,73 years,2,0,Counties in metropolitan areas ge 1 million pop
902,2395,Female,2019,Alive at last contact,001,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,63 years,2,0,Counties in metropolitan areas ge 1 million pop
904,2397,Female,2019,Alive at last contact,002,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,Malignant,Malignant,Breast,8520,Unknown,9,9,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,63 years,3,0,Counties in metropolitan areas ge 1 million pop
909,2406,Female,2019,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,"Recommended, unknown if administered",HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,53 years,2,0,Counties in metropolitan areas ge 1 million pop
946,2494,Female,2019,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,65 years,2,0,Counties in metropolitan areas ge 1 million pop
963,2528,Female,2019,Alive at last contact,006,30,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,61 years,2,0,Counties in metropolitan areas ge 1 million pop
966,2542,Female,2019,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Unknown,M,M,Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Breast DCIS,Left - origin of primary,In situ,75 years,3,0,Counties in metropolitan areas ge 1 million pop
968,2545,Female,2019,Alive at last contact,001,42,No radiation and/or cancer-directed surgery,Systemic therapy before surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Negative,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,3,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,63 years,2,0,Counties in metropolitan areas ge 1 million pop
1,3,Female,2018,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,9,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,70 years,2,0,Counties in metropolitan areas ge 1 million pop
13,28,Female,2018,Alive at last contact,002,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Unknown,2,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,66 years,2,0,Counties in metropolitan areas ge 1 million pop
19,41,Female,2018,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,69 years,2,0,Counties in metropolitan areas ge 1 million pop
20,42,Female,2018,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,2,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
24,51,Female,2018,2018,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8540,Unknown,9,9,XIf6 Carcinomas of breast,"8540/3: Paget disease, mammary","8540/3: Paget disease, mammary",Breast Invasive,Right - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
44,87,Female,2018,Alive at last contact,003,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8480,Unknown,1,1,XIf6 Carcinomas of breast,8480/3: Mucinous adenocarcinoma,8480/3: Mucinous adenocarcinoma,Breast Invasive,Right - origin of primary,Localized,63 years,2,0,Counties in metropolitan areas ge 1 million pop
49,94,Female,2018,Alive at last contact,001,42,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,In situ,In situ,Breast,8500,Unknown,2,2,Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Breast DCIS,Right - origin of primary,In situ,83 years,4,0,Counties in metropolitan areas ge 1 million pop
57,108,Female,2018,Alive at last contact,000,30,No radiation and/or cancer-directed surgery,Systemic therapy both before and after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2+,Positive,Borderline/Unknown,Positive,Malignant,Malignant,Breast,8500,Unknown,2,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,61 years,2,0,Counties in metropolitan areas ge 1 million pop
59,111,Female,2018,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8201,Unknown,9,2,Not classified by SEER or in situ,8201/2: Cribriform carcinoma in situ,In situ,Breast DCIS,Right - origin of primary,In situ,54 years,2,0,Counties in metropolitan areas ge 1 million pop
66,126,Female,2018,Alive at last contact,001,20,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,1,1,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,70 years,4,0,Counties in metropolitan areas ge 1 million pop
68,128,Female,2018,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Unknown,C,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,85 years,2,0,Counties in metropolitan areas ge 1 million pop
69,132,Female,2018,Alive at last contact,001,44,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Unknown,2,2,XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Breast Invasive,Left - origin of primary,Regional,62 years,3,0,Counties in metropolitan areas ge 1 million pop
115,217,Female,2018,Alive at last contact,001,0,Radiation after surgery,Systemic therapy after surgery,Not recommended,Yes,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8140,Unknown,9,9,XIf6 Carcinomas of breast,"8140/3: Adenocarcinoma, NOS","8140/3: Adenocarcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,81 years,4,0,Counties in metropolitan areas ge 1 million pop
122,229,Female,2018,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,2,2,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,84 years,3,0,Counties in metropolitan areas ge 1 million pop
126,234,Female,2018,Alive at last contact,002,30,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,44 years,2,0,Counties in metropolitan areas ge 1 million pop
162,320,Female,2018,Alive at last contact,001,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,1,1,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,71 years,11,0,Counties in metropolitan areas ge 1 million pop
166,336,Female,2018,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,9,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,58 years,3,0,Counties in metropolitan areas ge 1 million pop
167,339,Female,2018,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8480,Unknown,1,1,XIf6 Carcinomas of breast,8480/3: Mucinous adenocarcinoma,8480/3: Mucinous adenocarcinoma,Breast Invasive,Right - origin of primary,Localized,82 years,3,0,Counties in metropolitan areas ge 1 million pop
174,358,Female,2018,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,83 years,3,0,Counties in metropolitan areas ge 1 million pop
187,396,Female,2018,Alive at last contact,002,21,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,1,2,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,75 years,2,0,Counties in metropolitan areas ge 1 million pop
201,449,Female,2018,Alive at last contact,001,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,90+ years,4,0,Counties in metropolitan areas ge 1 million pop
218,539,Female,2018,Alive at last contact,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Not recommended, contraindicated due to other cond; autopsy only (1973-2002)",No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,89 years,3,0,Counties in metropolitan areas ge 1 million pop
231,588,Female,2018,Alive at last contact,002,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,90+ years,5,0,Counties in metropolitan areas ge 1 million pop
232,589,Female,2018,Alive at last contact,002,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Unknown,1,9,XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Breast Invasive,Right - origin of primary,Localized,90+ years,5,0,Counties in metropolitan areas ge 1 million pop
247,648,Female,2018,Alive at last contact,001,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,79 years,2,0,Counties in metropolitan areas ge 1 million pop
250,657,Female,2018,Alive at last contact,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Unknown,L,M,Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Breast DCIS,Left - origin of primary,In situ,71 years,3,0,Counties in metropolitan areas ge 1 million pop
251,658,Female,2018,2020,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Refused (1988+),HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8480,Unknown,1,2,XIf6 Carcinomas of breast,8480/3: Mucinous adenocarcinoma,8480/3: Mucinous adenocarcinoma,Breast Invasive,Right - origin of primary,Localized,67 years,3,0,Counties in metropolitan areas ge 1 million pop
254,670,Female,2018,2019,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
255,673,Female,2018,2020,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,83 years,5,0,Counties in metropolitan areas ge 1 million pop
256,675,Female,2018,Alive at last contact,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,71 years,2,0,Counties in metropolitan areas ge 1 million pop
260,691,Female,2018,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Refused (1988+),HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,82 years,2,0,Counties in metropolitan areas ge 1 million pop
263,695,Female,2018,2020,000,41,Radiation after surgery,Systemic therapy both before and after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Unknown,9,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,68 years,2,0,Counties in metropolitan areas ge 1 million pop
268,705,Female,2018,Alive at last contact,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,2,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Distant,72 years,2,0,Counties in metropolitan areas ge 1 million pop
307,812,Female,2018,Alive at last contact,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,9,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,75 years,2,0,Counties in metropolitan areas ge 1 million pop
321,847,Female,2018,Alive at last contact,001,30,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,76 years,2,0,Counties in metropolitan areas ge 1 million pop
330,875,Female,2018,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
344,917,Female,2018,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,69 years,3,0,Counties in metropolitan areas ge 1 million pop
357,947,Female,2018,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,76 years,2,0,Counties in metropolitan areas ge 1 million pop
358,948,Female,2018,2019,003,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,3,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Distant,81 years,2,0,Counties in metropolitan areas ge 1 million pop
386,1019,Female,2018,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8500,Unknown,M,M,Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Breast DCIS,Left - origin of primary,In situ,77 years,3,1,Counties in metropolitan areas ge 1 million pop
402,1074,Female,2018,Alive at last contact,000,30,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,9,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,81 years,2,0,Counties in metropolitan areas ge 1 million pop
408,1097,Female,2018,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,82 years,3,0,Counties in metropolitan areas ge 1 million pop
410,1101,Female,2018,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,72 years,2,0,Counties in metropolitan areas ge 1 million pop
417,1117,Female,2018,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,66 years,3,0,Counties in metropolitan areas ge 1 million pop
425,1144,Female,2018,Alive at last contact,002,20,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,Malignant,Malignant,Breast,8500,Unknown,B,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Unknown/unstaged,66 years,4,0,Counties in metropolitan areas ge 1 million pop
438,1183,Female,2018,Alive at last contact,001,40,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,77 years,3,0,Counties in metropolitan areas ge 1 million pop
439,1184,Female,2018,Alive at last contact,001,40,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,77 years,3,0,Counties in metropolitan areas ge 1 million pop
473,1279,Female,2018,Alive at last contact,002,42,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,54 years,5,0,Counties in metropolitan areas ge 1 million pop
475,1288,Female,2018,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,1,1,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,74 years,3,0,Counties in metropolitan areas ge 1 million pop
506,1369,Female,2018,Alive at last contact,002,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,L,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,79 years,3,0,Counties in metropolitan areas ge 1 million pop
508,1371,Female,2018,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Regional,64 years,2,0,Counties in metropolitan areas ge 1 million pop
510,1378,Female,2018,Alive at last contact,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,9,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,77 years,2,0,Counties in metropolitan areas ge 1 million pop
524,1424,Male,2018,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,51 years,3,0,Counties in metropolitan areas ge 1 million pop
525,1425,Male,2018,Alive at last contact,000,42,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,51 years,3,0,Counties in metropolitan areas ge 1 million pop
526,1427,Female,2018,Alive at last contact,000,51,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,2,2,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Left - origin of primary,Regional,67 years,2,0,Counties in metropolitan areas ge 1 million pop
576,1566,Female,2018,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,9,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,67 years,2,0,Counties in metropolitan areas ge 1 million pop
587,1597,Female,2018,Alive at last contact,001,24,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,73 years,2,0,Counties in metropolitan areas ge 1 million pop
592,1611,Female,2018,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Unknown,2,2,XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Breast Invasive,Left - origin of primary,Localized,84 years,3,0,Counties in metropolitan areas ge 1 million pop
594,1618,Female,2018,Alive at last contact,000,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,Malignant,Malignant,Breast,8500,Unknown,B,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,67 years,2,0,Counties in metropolitan areas ge 1 million pop
607,1652,Female,2018,Alive at last contact,000,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,Yes,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Unknown,2,9,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,83 years,3,0,Counties in metropolitan areas ge 1 million pop
613,1663,Female,2018,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,65 years,3,0,Counties in metropolitan areas ge 1 million pop
660,1789,Female,2018,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,59 years,2,0,Counties in metropolitan areas ge 1 million pop
688,1884,Female,2018,2018,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8000,Unknown,9,9,XIIb Other unspecified malignant tumors,"8000/3: Neoplasm, malignant","8000/3: Neoplasm, malignant",Breast Invasive,Left - origin of primary,Unknown/unstaged,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
689,1885,Female,2018,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Unknown,H,H,Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Breast DCIS,Left - origin of primary,In situ,59 years,5,0,Counties in metropolitan areas ge 1 million pop
700,1913,Female,2018,Alive at last contact,004,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8501,Unknown,H,H,Not classified by SEER or in situ,"8501/2: Comedocarcinoma, noninfiltrating",In situ,Breast DCIS,Right - origin of primary,In situ,72 years,2,0,Counties in metropolitan areas ge 1 million pop
701,1915,Female,2018,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Unknown,1,1,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,73 years,3,0,Counties in metropolitan areas ge 1 million pop
706,1929,Female,2018,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,"Recommended, unknown if administered",HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,72 years,4,0,Counties in metropolitan areas ge 1 million pop
707,1930,Female,2018,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,"Recommended, unknown if administered",HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,72 years,4,0,Counties in metropolitan areas ge 1 million pop
717,1955,Female,2018,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8500,Unknown,9,M,Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Breast DCIS,Left - origin of primary,In situ,58 years,2,0,Counties in metropolitan areas ge 1 million pop
722,1961,Female,2018,2020,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,85 years,2,0,Counties in metropolitan areas ge 1 million pop
755,2031,Female,2018,Alive at last contact,000,24,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,86 years,2,0,Counties in metropolitan areas ge 1 million pop
758,2043,Female,2018,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Unknown,2,2,XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Breast Invasive,Right - origin of primary,Localized,82 years,3,0,Counties in metropolitan areas ge 1 million pop
762,2052,Female,2018,2020,002,51,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
763,2053,Female,2018,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,9,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Regional,86 years,2,0,Counties in metropolitan areas ge 1 million pop
770,2067,Female,2018,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Unknown,A,1,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,73 years,2,0,Counties in metropolitan areas ge 1 million pop
784,2091,Female,2018,Alive at last contact,001,23,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,82 years,2,0,Counties in metropolitan areas ge 1 million pop
793,2119,Female,2018,Alive at last contact,002,21,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Unknown,1,1,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,71 years,2,0,Counties in metropolitan areas ge 1 million pop
822,2205,Female,2018,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,3,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,75 years,2,0,Counties in metropolitan areas ge 1 million pop
839,2253,Female,2018,Alive at last contact,000,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Unknown,9,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,74 years,3,0,Counties in metropolitan areas ge 1 million pop
844,2265,Female,2018,2018,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Not recommended, contraindicated due to other cond; autopsy only (1973-2002)",No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Distant,86 years,2,0,Counties in metropolitan areas ge 1 million pop
854,2297,Female,2018,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,2,2,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,68 years,3,0,Counties in metropolitan areas ge 1 million pop
855,2300,Female,2018,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,84 years,4,0,Counties in metropolitan areas ge 1 million pop
863,2320,Female,2018,2019,000,0,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Distant,76 years,2,0,Counties in metropolitan areas ge 1 million pop
868,2329,Female,2018,Alive at last contact,001,30,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,46 years,2,0,Counties in metropolitan areas ge 1 million pop
893,2384,Female,2018,Alive at last contact,000,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Localized,70 years,3,0,Counties in metropolitan areas ge 1 million pop
906,2401,Female,2018,2019,001,42,Radiation after surgery,Systemic therapy before surgery,Surgery performed,Yes,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,3,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,79 years,2,0,Counties in metropolitan areas ge 1 million pop
910,2407,Female,2018,2018,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8500,Unknown,9,9,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Unknown/unstaged,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
911,2410,Female,2018,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,1,1,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,68 years,3,0,Counties in metropolitan areas ge 1 million pop
925,2438,Female,2018,Alive at last contact,001,51,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,2,3,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Right - origin of primary,Regional,64 years,2,0,Counties in metropolitan areas ge 1 million pop
933,2460,Female,2018,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Unknown,1,1,XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Breast Invasive,Right - origin of primary,Localized,87 years,3,0,Counties in metropolitan areas ge 1 million pop
958,2519,Female,2018,Alive at last contact,001,49,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,1,1,XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Breast Invasive,Left - origin of primary,Regional,50 years,2,0,Counties in metropolitan areas ge 1 million pop
960,2524,Female,2018,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Unknown,A,1,XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Breast Invasive,Right - origin of primary,Localized,65 years,2,0,Counties in metropolitan areas ge 1 million pop
974,2569,Female,2018,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8504,Unknown,9,L,Not classified by SEER or in situ,8504/2: Noninfiltrating intracystic carcinoma,In situ,Breast DCIS,Left - origin of primary,In situ,79 years,3,0,Counties in metropolitan areas ge 1 million pop
11,25,Female,2017,Alive at last contact,001,30,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Negative,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,61 years,6,0,Counties in metropolitan areas ge 1 million pop
36,68,Female,2017,Alive at last contact,000,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,74 years,2,0,Counties in metropolitan areas ge 1 million pop
39,78,Female,2017,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,65 years,2,0,Counties in metropolitan areas ge 1 million pop
40,81,Female,2017,2019,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,45 years,2,0,Counties in metropolitan areas ge 1 million pop
43,85,Female,2017,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8522,Well differentiated; Grade I,Blank(s),Blank(s),Not classified by SEER or in situ,8522/2: Intraductal and lobular in situ carcinoma,In situ,Blank(s),Left - origin of primary,In situ,67 years,2,0,Counties in metropolitan areas ge 1 million pop
56,107,Female,2017,2018,003,30,No radiation and/or cancer-directed surgery,Systemic therapy both before and after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,57 years,2,0,Counties in metropolitan areas ge 1 million pop
90,178,Female,2017,Alive at last contact,001,30,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,58 years,2,0,Counties in metropolitan areas ge 1 million pop
97,189,Female,2017,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Localized,68 years,2,0,Counties in metropolitan areas ge 1 million pop
98,191,Female,2017,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Left - origin of primary,Localized,75 years,2,0,Counties in metropolitan areas ge 1 million pop
107,204,Female,2017,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,61 years,3,0,Counties in metropolitan areas ge 1 million pop
114,216,Female,2017,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,73 years,3,0,Counties in metropolitan areas ge 1 million pop
138,269,Female,2017,Alive at last contact,002,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8520,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8520/2: Lobular carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,76 years,2,0,Counties in metropolitan areas ge 1 million pop
143,276,Female,2017,2017,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,Yes,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,86 years,2,0,Counties in metropolitan areas ge 1 million pop
145,278,Female,2017,Alive at last contact,001,49,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Localized,77 years,2,0,Counties in metropolitan areas ge 1 million pop
175,360,Female,2017,2020,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,69 years,2,0,Counties in metropolitan areas ge 1 million pop
177,364,Female,2017,Alive at last contact,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
185,393,Female,2017,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,73 years,2,0,Counties in metropolitan areas ge 1 million pop
191,420,Female,2017,Alive at last contact,003,47,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,66 years,2,0,Counties in metropolitan areas ge 1 million pop
211,507,Female,2017,Alive at last contact,001,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,71 years,2,0,Counties in metropolitan areas ge 1 million pop
248,655,Female,2017,Alive at last contact,001,24,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8507,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8507/3: Ductal carcinoma, micropapillary","8507/3: Ductal carcinoma, micropapillary",Blank(s),Right - origin of primary,Localized,76 years,4,0,Counties in metropolitan areas ge 1 million pop
252,668,Female,2017,Alive at last contact,001,40,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,85 years,2,0,Counties in metropolitan areas ge 1 million pop
272,714,Female,2017,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,70 years,3,0,Counties in metropolitan areas ge 1 million pop
283,743,Female,2017,Alive at last contact,001,20,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8480,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8480/3: Mucinous adenocarcinoma,8480/3: Mucinous adenocarcinoma,Blank(s),Left - origin of primary,Localized,70 years,3,0,Counties in metropolitan areas ge 1 million pop
285,746,Female,2017,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,76 years,3,0,Counties in metropolitan areas ge 1 million pop
294,764,Female,2017,Alive at last contact,001,49,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Negative,Negative,Borderline/Unknown,In situ,In situ,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Right - origin of primary,In situ,57 years,3,0,Counties in metropolitan areas ge 1 million pop
298,785,Female,2017,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,90+ years,3,0,Counties in metropolitan areas ge 1 million pop
314,832,Female,2017,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,83 years,2,0,Counties in metropolitan areas ge 1 million pop
349,924,Female,2017,2018,000,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Negative,Negative,Borderline/Unknown,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,86 years,2,0,Counties in metropolitan areas ge 1 million pop
398,1051,Female,2017,2020,000,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,Yes,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Distant,63 years,2,0,Counties in metropolitan areas ge 1 million pop
406,1089,Female,2017,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,67 years,2,0,Counties in metropolitan areas ge 1 million pop
423,1135,Female,2017,Alive at last contact,000,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8523,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,74 years,2,0,Counties in metropolitan areas ge 1 million pop
442,1189,Female,2017,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,63 years,3,0,Counties in metropolitan areas ge 1 million pop
448,1199,Female,2017,2019,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,58 years,2,0,Counties in metropolitan areas ge 1 million pop
450,1202,Female,2017,Alive at last contact,003,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,67 years,2,0,Counties in metropolitan areas ge 1 million pop
466,1233,Female,2017,Alive at last contact,001,52,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Regional,67 years,2,0,Counties in metropolitan areas ge 1 million pop
469,1246,Female,2017,Alive at last contact,002,20,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,84 years,2,1,Counties in metropolitan areas ge 1 million pop
485,1314,Female,2017,Alive at last contact,004,51,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,73 years,4,0,Counties in metropolitan areas ge 1 million pop
488,1318,Female,2017,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,73 years,2,0,Counties in metropolitan areas ge 1 million pop
509,1376,Female,2017,Alive at last contact,000,0,Radiation after surgery,Systemic therapy after surgery,Not recommended,Yes,"Radiation, NOS  method or source not specified",HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,64 years,3,0,Counties in metropolitan areas ge 1 million pop
547,1490,Female,2017,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,64 years,3,0,Counties in metropolitan areas ge 1 million pop
572,1555,Female,2017,Alive at last contact,001,20,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,82 years,2,0,Counties in metropolitan areas ge 1 million pop
578,1569,Female,2017,Alive at last contact,001,43,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,66 years,2,0,Counties in metropolitan areas ge 1 million pop
579,1570,Female,2017,Alive at last contact,002,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,75 years,2,0,Counties in metropolitan areas ge 1 million pop
580,1573,Female,2017,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,76 years,2,0,Counties in metropolitan areas ge 1 million pop
599,1626,Female,2017,Alive at last contact,002,45,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,61 years,2,0,Counties in metropolitan areas ge 1 million pop
609,1657,Female,2017,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,70 years,2,0,Counties in metropolitan areas ge 1 million pop
615,1665,Female,2017,Alive at last contact,002,30,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,62 years,3,0,Counties in metropolitan areas ge 1 million pop
629,1703,Female,2017,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,60 years,2,0,Counties in metropolitan areas ge 1 million pop
630,1704,Female,2017,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,57 years,2,0,Counties in metropolitan areas ge 1 million pop
652,1764,Female,2017,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,49 years,2,0,Counties in metropolitan areas ge 1 million pop
681,1867,Female,2017,Alive at last contact,002,20,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,58 years,2,0,Counties in metropolitan areas ge 1 million pop
696,1901,Female,2017,Alive at last contact,001,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,84 years,2,0,Counties in metropolitan areas ge 1 million pop
715,1947,Female,2017,Alive at last contact,001,45,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,64 years,3,0,Counties in metropolitan areas ge 1 million pop
719,1957,Female,2017,Alive at last contact,002,22,Intraoperative radiation,Systemic therapy after surgery,Surgery performed,No/Unknown,Radioactive implants (includes brachytherapy) (1988+),HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,75 years,2,0,Counties in metropolitan areas ge 1 million pop
728,1977,Female,2017,Alive at last contact,002,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Well differentiated; Grade I,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,65 years,2,0,Counties in metropolitan areas ge 1 million pop
732,1983,Female,2017,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,74 years,3,0,Counties in metropolitan areas ge 1 million pop
764,2054,Female,2017,Alive at last contact,000,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,81 years,2,0,Counties in metropolitan areas ge 1 million pop
781,2085,Female,2017,Alive at last contact,000,30,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,Unknown,Negative,Negative,Borderline/Unknown,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,57 years,2,0,Counties in metropolitan areas ge 1 million pop
791,2115,Female,2017,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,73 years,2,0,Counties in metropolitan areas ge 1 million pop
801,2136,Female,2017,Alive at last contact,001,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Right - origin of primary,Localized,66 years,2,0,Counties in metropolitan areas ge 1 million pop
838,2251,Female,2017,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,84 years,3,0,Counties in metropolitan areas ge 1 million pop
861,2313,Female,2017,Alive at last contact,000,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8211,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8211/3: Tubular adenocarcinoma,8211/3: Tubular adenocarcinoma,Blank(s),Right - origin of primary,Localized,51 years,2,0,Counties in metropolitan areas ge 1 million pop
913,2415,Female,2017,Alive at last contact,002,30,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Right - origin of primary,Localized,52 years,2,0,Counties in metropolitan areas ge 1 million pop
916,2421,Female,2017,Alive at last contact,002,20,Radiation after surgery,Systemic therapy before surgery,Surgery performed,Yes,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8520,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,85 years,5,0,Counties in metropolitan areas ge 1 million pop
918,2429,Female,2017,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,83 years,2,0,Counties in metropolitan areas ge 1 million pop
923,2436,Female,2017,2017,000,51,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8575,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8575/3: Metaplastic carcinoma, NOS","8575/3: Metaplastic carcinoma, NOS",Blank(s),Right - origin of primary,Regional,90+ years,4,0,Counties in metropolitan areas ge 1 million pop
924,2437,Female,2017,2017,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8480,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8480/3: Mucinous adenocarcinoma,8480/3: Mucinous adenocarcinoma,Blank(s),Left - origin of primary,Localized,90+ years,4,0,Counties in metropolitan areas ge 1 million pop
949,2500,Female,2017,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,73 years,2,0,Counties in metropolitan areas ge 1 million pop
953,2512,Female,2017,2020,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8520/2: Lobular carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,73 years,5,0,Counties in metropolitan areas ge 1 million pop
954,2513,Female,2017,2020,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8520/2: Lobular carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,73 years,5,0,Counties in metropolitan areas ge 1 million pop
961,2526,Female,2017,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8201,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,8201/2: Cribriform carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,89 years,3,0,Counties in metropolitan areas ge 1 million pop
973,2566,Female,2017,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,75 years,2,0,Counties in metropolitan areas ge 1 million pop
975,2575,Female,2017,Alive at last contact,002,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,71 years,2,0,Counties in metropolitan areas ge 1 million pop
981,2591,Female,2017,2018,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended but not performed, patient refused",No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,85 years,2,0,Counties in metropolitan areas ge 1 million pop
12,27,Female,2016,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,70 years,2,0,Counties in metropolitan areas ge 1 million pop
58,110,Female,2016,Alive at last contact,003,49,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,56 years,2,0,Counties in metropolitan areas ge 1 million pop
88,167,Female,2016,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,70 years,2,0,Counties in metropolitan areas ge 1 million pop
102,196,Female,2016,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,48 years,2,0,Counties in metropolitan areas ge 1 million pop
121,226,Female,2016,Alive at last contact,001,30,No radiation and/or cancer-directed surgery,Systemic therapy before surgery,Surgery performed,Yes,None/Unknown,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,44 years,2,0,Counties in metropolitan areas ge 1 million pop
150,283,Female,2016,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8211,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8211/3: Tubular adenocarcinoma,8211/3: Tubular adenocarcinoma,Blank(s),Left - origin of primary,Localized,77 years,2,0,Counties in metropolitan areas ge 1 million pop
152,294,Female,2016,2020,000,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,84 years,4,0,Counties in metropolitan areas ge 1 million pop
239,617,Female,2016,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,77 years,2,1,Counties in metropolitan areas ge 1 million pop
271,713,Female,2016,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Regional,71 years,4,0,Counties in metropolitan areas ge 1 million pop
290,755,Female,2016,Alive at last contact,002,42,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8501,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8501/2: Comedocarcinoma, noninfiltrating",In situ,Blank(s),Right - origin of primary,In situ,64 years,2,0,Counties in metropolitan areas ge 1 million pop
292,760,Female,2016,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,71 years,3,0,Counties in metropolitan areas ge 1 million pop
293,761,Female,2016,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,71 years,3,0,Counties in metropolitan areas ge 1 million pop
308,815,Female,2016,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,84 years,2,0,Counties in metropolitan areas ge 1 million pop
335,883,Female,2016,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,68 years,2,0,Counties in metropolitan areas ge 1 million pop
341,897,Female,2016,2020,002,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,80 years,2,0,Counties in metropolitan areas ge 1 million pop
345,918,Female,2016,Alive at last contact,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,68 years,2,0,Counties in metropolitan areas ge 1 million pop
347,921,Female,2016,Alive at last contact,001,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,81 years,2,0,Counties in metropolitan areas ge 1 million pop
348,923,Female,2016,2019,001,22,Radiation before and after surgery,Systemic therapy both before and after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Distant,65 years,2,0,Counties in metropolitan areas ge 1 million pop
352,932,Female,2016,Alive at last contact,004,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,87 years,2,0,Counties in metropolitan areas ge 1 million pop
369,987,Female,2016,Alive at last contact,002,49,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8230,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8230/2: Ductal carcinoma in situ, solid type",In situ,Blank(s),Right - origin of primary,In situ,51 years,2,0,Counties in metropolitan areas ge 1 million pop
377,1005,Female,2016,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,Systemic therapy both before and after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,70 years,2,0,Counties in metropolitan areas ge 1 million pop
404,1081,Female,2016,Alive at last contact,000,20,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8501,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8501/2: Comedocarcinoma, noninfiltrating",In situ,Blank(s),Right - origin of primary,In situ,71 years,3,0,Counties in metropolitan areas ge 1 million pop
432,1164,Female,2016,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8503,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,8503/3: Intraductal papillary adenocarcinoma with invasion,8503/3: Intraductal papillary adenocarcinoma with invasion,Blank(s),Right - origin of primary,Localized,84 years,2,0,Counties in metropolitan areas ge 1 million pop
443,1191,Male,2016,2017,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Distant,65 years,2,0,Counties in metropolitan areas ge 1 million pop
459,1216,Female,2016,2018,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,76 years,3,0,Counties in metropolitan areas ge 1 million pop
471,1253,Female,2016,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8520,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8520/2: Lobular carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,59 years,2,0,Counties in metropolitan areas ge 1 million pop
501,1355,Female,2016,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8510,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8510/3: Medullary carcinoma, NOS","8510/3: Medullary carcinoma, NOS",Blank(s),Left - origin of primary,Localized,52 years,2,0,Counties in metropolitan areas ge 1 million pop
505,1367,Female,2016,Alive at last contact,003,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,83 years,2,0,Counties in metropolitan areas ge 1 million pop
512,1384,Female,2016,Alive at last contact,000,0,Radiation after surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,83 years,2,0,Counties in metropolitan areas ge 1 million pop
513,1387,Female,2016,Alive at last contact,001,40,Radiation after surgery,Systemic therapy before surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Regional,70 years,3,0,Counties in metropolitan areas ge 1 million pop
515,1389,Female,2016,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8230,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8230/2: Ductal carcinoma in situ, solid type",In situ,Blank(s),Left - origin of primary,In situ,80 years,2,0,Counties in metropolitan areas ge 1 million pop
534,1450,Female,2016,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,77 years,4,0,Counties in metropolitan areas ge 1 million pop
537,1457,Female,2016,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,72 years,3,0,Counties in metropolitan areas ge 1 million pop
552,1505,Female,2016,Alive at last contact,000,20,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,76 years,3,0,Counties in metropolitan areas ge 1 million pop
560,1528,Female,2016,Alive at last contact,001,41,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,73 years,3,0,Counties in metropolitan areas ge 1 million pop
561,1533,Female,2016,Alive at last contact,000,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8480,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8480/3: Mucinous adenocarcinoma,8480/3: Mucinous adenocarcinoma,Blank(s),Left - origin of primary,Localized,77 years,2,0,Counties in metropolitan areas ge 1 million pop
564,1537,Female,2016,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Right - origin of primary,In situ,72 years,2,0,Counties in metropolitan areas ge 1 million pop
577,1567,Female,2016,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,71 years,3,0,Counties in metropolitan areas ge 1 million pop
584,1586,Female,2016,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,55 years,2,0,Counties in metropolitan areas ge 1 million pop
585,1588,Female,2016,2017,005,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Distant,69 years,2,0,Counties in metropolitan areas ge 1 million pop
606,1651,Female,2016,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,61 years,2,0,Counties in metropolitan areas ge 1 million pop
614,1664,Female,2016,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,61 years,3,0,Counties in metropolitan areas ge 1 million pop
621,1681,Female,2016,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,75 years,2,0,Counties in metropolitan areas ge 1 million pop
622,1682,Female,2016,Alive at last contact,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,64 years,4,0,Counties in metropolitan areas ge 1 million pop
641,1735,Female,2016,Alive at last contact,001,40,Radiation after surgery,Systemic therapy both before and after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,65 years,2,0,Counties in metropolitan areas ge 1 million pop
656,1773,Female,2016,Alive at last contact,002,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,87 years,4,0,Counties in metropolitan areas ge 1 million pop
674,1848,Female,2016,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Radioactive implants (includes brachytherapy) (1988+),HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8523,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Right - origin of primary,Localized,66 years,2,0,Counties in metropolitan areas ge 1 million pop
691,1893,Female,2016,Alive at last contact,001,52,No radiation and/or cancer-directed surgery,Systemic therapy before surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,58 years,2,0,Counties in metropolitan areas ge 1 million pop
718,1956,Female,2016,Alive at last contact,001,45,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,62 years,2,0,Counties in metropolitan areas ge 1 million pop
739,2002,Female,2016,Alive at last contact,002,22,Intraoperative radiation,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,69 years,2,0,Counties in metropolitan areas ge 1 million pop
750,2021,Female,2016,2019,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
761,2049,Female,2016,2016,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,86 years,2,0,Counties in metropolitan areas ge 1 million pop
767,2062,Female,2016,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,80 years,3,0,Counties in metropolitan areas ge 1 million pop
775,2074,Female,2016,2020,002,51,No radiation and/or cancer-directed surgery,Systemic therapy before surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Regional,59 years,5,0,Counties in metropolitan areas ge 1 million pop
785,2094,Female,2016,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,43 years,3,0,Counties in metropolitan areas ge 1 million pop
814,2172,Female,2016,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Localized,78 years,3,0,Counties in metropolitan areas ge 1 million pop
815,2175,Female,2016,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,76 years,2,0,Counties in metropolitan areas ge 1 million pop
836,2247,Female,2016,Alive at last contact,002,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8523,Undifferentiated; anaplastic; Grade IV,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,68 years,3,0,Counties in metropolitan areas ge 1 million pop
841,2262,Female,2016,Alive at last contact,002,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Regional,81 years,3,0,Counties in metropolitan areas ge 1 million pop
842,2263,Female,2016,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,62 years,3,0,Counties in metropolitan areas ge 1 million pop
853,2296,Female,2016,Alive at last contact,000,46,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,72 years,2,0,Counties in metropolitan areas ge 1 million pop
885,2363,Female,2016,Alive at last contact,000,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,66 years,2,0,Counties in metropolitan areas ge 1 million pop
888,2371,Female,2016,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,57 years,3,0,Counties in metropolitan areas ge 1 million pop
919,2430,Female,2016,Alive at last contact,004,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8520,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8520/2: Lobular carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,74 years,2,0,Counties in metropolitan areas ge 1 million pop
922,2434,Female,2016,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,73 years,2,0,Counties in metropolitan areas ge 1 million pop
929,2448,Female,2016,Alive at last contact,003,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Right - origin of primary,Localized,56 years,2,0,Counties in metropolitan areas ge 1 million pop
930,2451,Female,2016,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,61 years,3,0,Counties in metropolitan areas ge 1 million pop
934,2463,Female,2016,Alive at last contact,000,51,No radiation and/or cancer-directed surgery,Systemic therapy before surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,78 years,2,0,Counties in metropolitan areas ge 1 million pop
944,2485,Female,2016,2019,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Not recommended, contraindicated due to other cond; autopsy only (1973-2002)",No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,88 years,2,0,Counties in metropolitan areas ge 1 million pop
967,2544,Female,2016,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Localized,54 years,3,0,Counties in metropolitan areas ge 1 million pop
969,2550,Female,2016,Alive at last contact,003,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,70 years,2,0,Counties in metropolitan areas ge 1 million pop
977,2578,Female,2016,2017,000,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended but not performed, patient refused",No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,90+ years,4,0,Counties in metropolitan areas ge 1 million pop
993,2613,Female,2016,Alive at last contact,001,20,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,88 years,2,0,Counties in metropolitan areas ge 1 million pop
2,7,Female,2015,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Regional,54 years,2,0,Counties in metropolitan areas ge 1 million pop
9,20,Female,2015,2016,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Distant,75 years,2,0,Counties in metropolitan areas ge 1 million pop
10,24,Female,2015,2015,001,51,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,87 years,2,0,Counties in metropolitan areas ge 1 million pop
15,36,Female,2015,2019,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,84 years,2,0,Counties in metropolitan areas ge 1 million pop
22,47,Female,2015,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8510,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8510/3: Medullary carcinoma, NOS","8510/3: Medullary carcinoma, NOS",Blank(s),Right - origin of primary,Localized,61 years,4,0,Counties in metropolitan areas ge 1 million pop
27,55,Female,2015,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,74 years,3,0,Counties in metropolitan areas ge 1 million pop
30,58,Female,2015,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,60 years,3,0,Counties in metropolitan areas ge 1 million pop
32,63,Male,2015,2017,000,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,Yes,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8140,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8140/3: Adenocarcinoma, NOS","8140/3: Adenocarcinoma, NOS",Blank(s),"Paired site, but no information concerning laterality",Unknown/unstaged,77 years,2,0,Counties in metropolitan areas ge 1 million pop
41,82,Female,2015,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
45,88,Female,2015,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,80 years,3,0,Counties in metropolitan areas ge 1 million pop
46,89,Female,2015,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,80 years,3,0,Counties in metropolitan areas ge 1 million pop
47,92,Female,2015,Alive at last contact,003,30,No radiation and/or cancer-directed surgery,Systemic therapy before surgery,Surgery performed,Yes,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,56 years,2,0,Counties in metropolitan areas ge 1 million pop
52,98,Female,2015,Alive at last contact,001,40,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8480,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8480/3: Mucinous adenocarcinoma,8480/3: Mucinous adenocarcinoma,Blank(s),Left - origin of primary,Localized,85 years,4,0,Counties in metropolitan areas ge 1 million pop
53,99,Female,2015,Alive at last contact,001,40,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,85 years,4,0,Counties in metropolitan areas ge 1 million pop
76,142,Male,2015,Alive at last contact,001,41,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,82 years,2,0,Counties in metropolitan areas ge 1 million pop
83,158,Female,2015,Alive at last contact,002,49,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Regional,59 years,2,0,Counties in metropolitan areas ge 1 million pop
85,163,Female,2015,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,73 years,3,0,Counties in metropolitan areas ge 1 million pop
86,164,Female,2015,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8201,Well differentiated; Grade I,Blank(s),Blank(s),Not classified by SEER or in situ,8201/2: Cribriform carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,73 years,3,0,Counties in metropolitan areas ge 1 million pop
101,195,Female,2015,Alive at last contact,001,40,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,85 years,4,0,Counties in metropolitan areas ge 1 million pop
103,197,Female,2015,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,63 years,2,0,Counties in metropolitan areas ge 1 million pop
113,215,Female,2015,Alive at last contact,001,20,Intraoperative rad with other rad before/after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,"Radiation, NOS  method or source not specified",HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,87 years,3,0,Counties in metropolitan areas ge 1 million pop
119,223,Female,2015,2016,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
127,237,Female,2015,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,90+ years,3,0,Counties in metropolitan areas ge 1 million pop
149,282,Female,2015,Alive at last contact,005,44,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8501,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8501/2: Comedocarcinoma, noninfiltrating",In situ,Blank(s),Right - origin of primary,In situ,68 years,2,0,Counties in metropolitan areas ge 1 million pop
163,321,Female,2015,Alive at last contact,002,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8230,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8230/2: Ductal carcinoma in situ, solid type",In situ,Blank(s),Left - origin of primary,In situ,60 years,3,0,Counties in metropolitan areas ge 1 million pop
179,372,Female,2015,Alive at last contact,001,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Negative,Negative,Borderline/Unknown,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,66 years,2,0,Counties in metropolitan areas ge 1 million pop
205,471,Female,2015,2020,002,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,90+ years,3,1,Counties in metropolitan areas ge 1 million pop
208,488,Female,2015,Alive at last contact,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Negative,Negative,Borderline/Unknown,In situ,In situ,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,77 years,3,0,Counties in metropolitan areas ge 1 million pop
209,495,Female,2015,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8520,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8520/2: Lobular carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,75 years,3,0,Counties in metropolitan areas ge 1 million pop
212,513,Female,2015,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,80 years,3,0,Counties in metropolitan areas ge 1 million pop
227,564,Female,2015,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,72 years,2,0,Counties in metropolitan areas ge 1 million pop
238,614,Female,2015,Alive at last contact,000,23,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,65 years,4,0,Counties in metropolitan areas ge 1 million pop
262,693,Female,2015,Alive at last contact,000,0,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8530,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8530/3: Inflammatory carcinoma,8530/3: Inflammatory carcinoma,Blank(s),Left - origin of primary,Distant,82 years,3,0,Counties in metropolitan areas ge 1 million pop
279,738,Female,2015,Alive at last contact,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Localized,74 years,4,0,Counties in metropolitan areas ge 1 million pop
280,739,Female,2015,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Localized,74 years,4,0,Counties in metropolitan areas ge 1 million pop
281,740,Female,2015,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,74 years,4,0,Counties in metropolitan areas ge 1 million pop
304,805,Female,2015,2015,000,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Unknown/unstaged,90+ years,4,0,Counties in metropolitan areas ge 1 million pop
306,808,Female,2015,Alive at last contact,001,30,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,64 years,4,0,Counties in metropolitan areas ge 1 million pop
323,852,Female,2015,Alive at last contact,002,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,84 years,2,0,Counties in metropolitan areas ge 1 million pop
333,880,Female,2015,Alive at last contact,001,22,Radiation after surgery,Systemic therapy before surgery,Surgery performed,Yes,Beam radiation,HR+/HER2+,Negative,Positive,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,66 years,2,0,Counties in metropolitan areas ge 1 million pop
339,891,Female,2015,2017,002,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,90+ years,4,0,Counties in metropolitan areas ge 1 million pop
343,915,Female,2015,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,75 years,3,0,Counties in metropolitan areas ge 1 million pop
346,919,Female,2015,Alive at last contact,003,20,Radiation after surgery,Systemic therapy both before and after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,59 years,3,0,Counties in metropolitan areas ge 1 million pop
363,965,Female,2015,Alive at last contact,001,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,70 years,2,0,Counties in metropolitan areas ge 1 million pop
368,984,Female,2015,2017,000,80,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8000,Unknown,Blank(s),Blank(s),XIIb Other unspecified malignant tumors,"8000/3: Neoplasm, malignant","8000/3: Neoplasm, malignant",Blank(s),"Paired site, but no information concerning laterality",Unknown/unstaged,70 years,2,0,Counties in metropolitan areas ge 1 million pop
374,998,Female,2015,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,74 years,2,0,Counties in metropolitan areas ge 1 million pop
380,1010,Female,2015,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,80 years,2,0,Counties in metropolitan areas ge 1 million pop
383,1015,Female,2015,Alive at last contact,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,75 years,2,0,Counties in metropolitan areas ge 1 million pop
392,1037,Female,2015,Alive at last contact,000,41,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,69 years,2,0,Counties in metropolitan areas ge 1 million pop
395,1048,Female,2015,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,82 years,4,0,Counties in metropolitan areas ge 1 million pop
396,1049,Female,2015,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,82 years,4,0,Counties in metropolitan areas ge 1 million pop
429,1159,Female,2015,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,57 years,2,0,Counties in metropolitan areas ge 1 million pop
444,1192,Female,2015,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,63 years,2,0,Counties in metropolitan areas ge 1 million pop
457,1212,Female,2015,Alive at last contact,001,20,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Negative,Negative,Borderline/Unknown,In situ,In situ,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,65 years,3,0,Counties in metropolitan areas ge 1 million pop
470,1249,Female,2015,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,71 years,2,0,Counties in metropolitan areas ge 1 million pop
489,1322,Female,2015,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,82 years,4,0,Counties in metropolitan areas ge 1 million pop
492,1325,Female,2015,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Localized,68 years,2,0,Counties in metropolitan areas ge 1 million pop
495,1336,Female,2015,2018,000,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8522,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,81 years,3,0,Counties in metropolitan areas ge 1 million pop
498,1349,Female,2015,2017,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,87 years,2,0,Counties in metropolitan areas ge 1 million pop
511,1381,Female,2015,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,71 years,3,0,Counties in metropolitan areas ge 1 million pop
514,1388,Female,2015,Alive at last contact,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,87 years,3,0,Counties in metropolitan areas ge 1 million pop
539,1463,Female,2015,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,70 years,2,0,Counties in metropolitan areas ge 1 million pop
542,1475,Female,2015,Alive at last contact,004,40,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,75 years,2,0,Counties in metropolitan areas ge 1 million pop
549,1496,Female,2015,Alive at last contact,002,40,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,62 years,3,0,Counties in metropolitan areas ge 1 million pop
557,1518,Female,2015,2020,000,22,Radiation after surgery,Systemic therapy both before and after surgery,Surgery performed,No/Unknown,Radioactive implants (includes brachytherapy) (1988+),HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,86 years,2,0,Counties in metropolitan areas ge 1 million pop
559,1524,Female,2015,Alive at last contact,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,87 years,4,0,Counties in metropolitan areas ge 1 million pop
582,1577,Female,2015,Alive at last contact,001,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Left - origin of primary,Regional,65 years,2,0,Counties in metropolitan areas ge 1 million pop
598,1623,Female,2015,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Right - origin of primary,Localized,74 years,3,0,Counties in metropolitan areas ge 1 million pop
605,1649,Female,2015,Alive at last contact,000,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Regional,72 years,2,0,Counties in metropolitan areas ge 1 million pop
611,1661,Female,2015,Alive at last contact,003,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,72 years,2,0,Counties in metropolitan areas ge 1 million pop
616,1666,Female,2015,Alive at last contact,002,22,Intraoperative radiation,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,"Radiation, NOS  method or source not specified",HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,72 years,2,0,Counties in metropolitan areas ge 1 million pop
618,1674,Female,2015,Alive at last contact,001,20,Intraoperative radiation,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,"Radiation, NOS  method or source not specified",HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,79 years,3,0,Counties in metropolitan areas ge 1 million pop
619,1677,Female,2015,2016,000,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,83 years,2,0,Counties in metropolitan areas ge 1 million pop
625,1691,Female,2015,2018,002,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,83 years,2,0,Counties in metropolitan areas ge 1 million pop
631,1707,Female,2015,Alive at last contact,002,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,82 years,2,0,Counties in metropolitan areas ge 1 million pop
642,1737,Female,2015,2018,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8522,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,77 years,3,1,Counties in metropolitan areas ge 1 million pop
694,1898,Female,2015,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,57 years,2,0,Counties in metropolitan areas ge 1 million pop
712,1942,Female,2015,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8504,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8504/2: Noninfiltrating intracystic carcinoma,In situ,Blank(s),Right - origin of primary,In situ,79 years,2,0,Counties in metropolitan areas ge 1 million pop
725,1966,Female,2015,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,66 years,5,0,Counties in metropolitan areas ge 1 million pop
730,1980,Female,2015,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,67 years,2,0,Counties in metropolitan areas ge 1 million pop
737,1995,Female,2015,2016,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended but not performed, patient refused",No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,73 years,2,0,Counties in metropolitan areas ge 1 million pop
748,2019,Female,2015,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy both before and after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,83 years,6,0,Counties in metropolitan areas ge 1 million pop
776,2075,Female,2015,Alive at last contact,007,20,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,52 years,2,0,Counties in metropolitan areas ge 1 million pop
792,2117,Female,2015,2020,002,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,72 years,3,0,Counties in metropolitan areas ge 1 million pop
818,2180,Female,2015,Alive at last contact,002,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended, unknown if performed",Yes,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,71 years,3,0,Counties in metropolitan areas ge 1 million pop
824,2213,Female,2015,Alive at last contact,000,40,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,75 years,3,0,Counties in metropolitan areas ge 1 million pop
832,2234,Female,2015,Alive at last contact,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8140,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8140/3: Adenocarcinoma, NOS","8140/3: Adenocarcinoma, NOS",Blank(s),Left - origin of primary,Regional,86 years,2,0,Counties in metropolitan areas ge 1 million pop
837,2248,Female,2015,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,76 years,2,0,Counties in metropolitan areas ge 1 million pop
875,2346,Female,2015,Alive at last contact,001,42,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,67 years,2,0,Counties in metropolitan areas ge 1 million pop
887,2370,Female,2015,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8507,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,8507/2: Intraductal micropapillary carcinoma,In situ,Blank(s),Left - origin of primary,In situ,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
892,2383,Female,2015,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,66 years,3,0,Counties in metropolitan areas ge 1 million pop
898,2390,Female,2015,Alive at last contact,002,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,49 years,3,0,Counties in metropolitan areas ge 1 million pop
899,2391,Female,2015,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,49 years,3,0,Counties in metropolitan areas ge 1 million pop
940,2480,Female,2015,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,73 years,2,0,Counties in metropolitan areas ge 1 million pop
952,2509,Female,2015,Alive at last contact,000,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8520,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8520/2: Lobular carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,54 years,2,0,Counties in metropolitan areas ge 1 million pop
964,2529,Female,2015,Alive at last contact,007,30,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,48 years,2,0,Counties in metropolitan areas ge 1 million pop
991,2610,Female,2015,Alive at last contact,003,30,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,69 years,3,0,Counties in metropolitan areas ge 1 million pop
992,2611,Female,2015,Alive at last contact,001,45,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,70 years,3,0,Counties in metropolitan areas ge 1 million pop
6,13,Female,2014,Alive at last contact,001,45,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,56 years,2,0,Counties in metropolitan areas ge 1 million pop
38,76,Female,2014,2017,001,51,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,87 years,2,0,Counties in metropolitan areas ge 1 million pop
50,95,Female,2014,Alive at last contact,002,49,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,45 years,2,0,Counties in metropolitan areas ge 1 million pop
81,156,Female,2014,Alive at last contact,001,48,No radiation and/or cancer-directed surgery,Systemic therapy before surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Regional,65 years,2,0,Counties in metropolitan areas ge 1 million pop
109,208,Female,2014,Alive at last contact,003,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,69 years,2,0,Counties in metropolitan areas ge 1 million pop
110,210,Female,2014,2015,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended but not performed, patient refused",No/Unknown,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,50 years,2,0,Counties in metropolitan areas ge 1 million pop
111,212,Female,2014,Alive at last contact,001,41,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,69 years,2,0,Counties in metropolitan areas ge 1 million pop
112,213,Female,2014,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,71 years,2,0,Counties in metropolitan areas ge 1 million pop
120,225,Female,2014,Alive at last contact,001,40,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8520,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,80 years,2,0,Counties in metropolitan areas ge 1 million pop
124,232,Female,2014,2015,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Regional,73 years,4,0,Counties in metropolitan areas ge 1 million pop
134,254,Female,2014,2018,001,55,No radiation and/or cancer-directed surgery,Systemic therapy before surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Distant,70 years,3,0,Counties in metropolitan areas ge 1 million pop
137,268,Female,2014,Alive at last contact,002,23,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,85 years,3,0,Counties in metropolitan areas ge 1 million pop
141,273,Female,2014,Alive at last contact,009,43,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8501,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8501/2: Comedocarcinoma, noninfiltrating",In situ,Blank(s),Left - origin of primary,In situ,57 years,2,0,Counties in metropolitan areas ge 1 million pop
155,301,Female,2014,2016,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Not recommended, contraindicated due to other cond; autopsy only (1973-2002)",No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,82 years,2,0,Counties in metropolitan areas ge 1 million pop
157,306,Female,2014,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,67 years,4,0,Counties in metropolitan areas ge 1 million pop
181,376,Female,2014,2015,002,20,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,68 years,3,0,Counties in metropolitan areas ge 1 million pop
197,433,Female,2014,Alive at last contact,001,45,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,60 years,2,0,Counties in metropolitan areas ge 1 million pop
223,550,Female,2014,2015,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
237,612,Female,2014,Alive at last contact,003,20,Radiation after surgery,Systemic therapy before surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,71 years,2,0,Counties in metropolitan areas ge 1 million pop
243,625,Female,2014,2016,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,71 years,2,0,Counties in metropolitan areas ge 1 million pop
282,742,Female,2014,Alive at last contact,000,23,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Left - origin of primary,Localized,67 years,3,0,Counties in metropolitan areas ge 1 million pop
320,843,Female,2014,2019,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,81 years,2,0,Counties in metropolitan areas ge 1 million pop
326,866,Female,2014,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Negative,Negative,Borderline/Unknown,In situ,In situ,Breast,8522,Undifferentiated; anaplastic; Grade IV,Blank(s),Blank(s),Not classified by SEER or in situ,8522/2: Intraductal and lobular in situ carcinoma,In situ,Blank(s),Left - origin of primary,In situ,68 years,3,0,Counties in metropolitan areas ge 1 million pop
334,881,Female,2014,2018,000,41,No radiation and/or cancer-directed surgery,Systemic therapy before surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,84 years,2,0,Counties in metropolitan areas ge 1 million pop
365,974,Female,2014,2020,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,70 years,3,0,Counties in metropolitan areas ge 1 million pop
366,978,Female,2014,Alive at last contact,001,40,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,59 years,3,0,Counties in metropolitan areas ge 1 million pop
382,1014,Female,2014,2017,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,78 years,2,0,Counties in metropolitan areas ge 1 million pop
389,1025,Female,2014,Alive at last contact,003,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,61 years,3,0,Counties in metropolitan areas ge 1 million pop
399,1055,Female,2014,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,86 years,3,0,Counties in metropolitan areas ge 1 million pop
409,1100,Female,2014,2018,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Right - origin of primary,Regional,70 years,2,0,Counties in metropolitan areas ge 1 million pop
419,1121,Female,2014,2018,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,83 years,2,0,Counties in metropolitan areas ge 1 million pop
435,1167,Female,2014,2016,001,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,69 years,3,0,Counties in metropolitan areas ge 1 million pop
437,1178,Female,2014,Alive at last contact,001,20,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,In situ,In situ,Breast,8501,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8501/2: Comedocarcinoma, noninfiltrating",In situ,Blank(s),Right - origin of primary,In situ,63 years,4,0,Counties in metropolitan areas ge 1 million pop
446,1196,Female,2014,Alive at last contact,001,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,62 years,2,0,Counties in metropolitan areas ge 1 million pop
456,1211,Female,2014,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,65 years,3,0,Counties in metropolitan areas ge 1 million pop
465,1231,Female,2014,2017,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,88 years,2,0,Counties in metropolitan areas ge 1 million pop
468,1244,Female,2014,Alive at last contact,001,20,Intraoperative rad with other rad before/after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,68 years,2,0,Counties in metropolitan areas ge 1 million pop
483,1310,Female,2014,2016,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,Beam radiation,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,54 years,3,0,Counties in metropolitan areas ge 1 million pop
491,1324,Female,2014,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Undifferentiated; anaplastic; Grade IV,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Right - origin of primary,In situ,68 years,2,0,Counties in metropolitan areas ge 1 million pop
493,1326,Female,2014,Alive at last contact,001,24,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,64 years,2,0,Counties in metropolitan areas ge 1 million pop
546,1489,Female,2014,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,61 years,3,0,Counties in metropolitan areas ge 1 million pop
548,1494,Female,2014,2017,000,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Distant,74 years,4,0,Counties in metropolitan areas ge 1 million pop
568,1546,Female,2014,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8504,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8504/3: Intracystic carcinoma, NOS","8504/3: Intracystic carcinoma, NOS",Blank(s),Right - origin of primary,Localized,66 years,2,0,Counties in metropolitan areas ge 1 million pop
581,1575,Female,2014,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,81 years,4,0,Counties in metropolitan areas ge 1 million pop
583,1579,Female,2014,2020,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,76 years,3,0,Counties in metropolitan areas ge 1 million pop
597,1622,Female,2014,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,73 years,3,0,Counties in metropolitan areas ge 1 million pop
604,1648,Female,2014,2015,002,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,63 years,3,0,Counties in metropolitan areas ge 1 million pop
608,1656,Female,2014,2020,001,20,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,71 years,3,0,Counties in metropolitan areas ge 1 million pop
624,1689,Female,2014,Alive at last contact,002,20,Radiation after surgery,Systemic therapy before surgery,Surgery performed,Yes,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,60 years,2,0,Counties in metropolitan areas ge 1 million pop
635,1720,Female,2014,2017,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8522,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
638,1727,Female,2014,Alive at last contact,001,45,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8523,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Left - origin of primary,Localized,59 years,2,0,Counties in metropolitan areas ge 1 million pop
645,1747,Female,2014,Alive at last contact,001,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
664,1808,Female,2014,Alive at last contact,002,53,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,78 years,3,0,Counties in metropolitan areas ge 1 million pop
672,1836,Female,2014,Alive at last contact,001,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8524,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8524/3: Infiltrating lobular mixed with other types of carcinoma,8524/3: Infiltrating lobular mixed with other types of carcinoma,Blank(s),Left - origin of primary,Regional,65 years,2,0,Counties in metropolitan areas ge 1 million pop
673,1837,Female,2014,Alive at last contact,002,20,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,60 years,2,0,Counties in metropolitan areas ge 1 million pop
727,1974,Female,2014,Alive at last contact,000,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,81 years,4,0,Counties in metropolitan areas ge 1 million pop
734,1985,Female,2014,Alive at last contact,000,20,Radiation after surgery,Systemic therapy both before and after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,58 years,2,0,Counties in metropolitan areas ge 1 million pop
743,2012,Female,2014,Alive at last contact,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Not recommended, contraindicated due to other cond; autopsy only (1973-2002)",No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,87 years,2,0,Counties in metropolitan areas ge 1 million pop
744,2014,Female,2014,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,76 years,3,0,Counties in metropolitan areas ge 1 million pop
753,2026,Female,2014,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8480,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8480/3: Mucinous adenocarcinoma,8480/3: Mucinous adenocarcinoma,Blank(s),Left - origin of primary,Localized,90+ years,4,0,Counties in metropolitan areas ge 1 million pop
754,2027,Female,2014,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8140,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8140/3: Adenocarcinoma, NOS","8140/3: Adenocarcinoma, NOS",Blank(s),Left - origin of primary,Localized,90+ years,4,0,Counties in metropolitan areas ge 1 million pop
771,2069,Female,2014,Alive at last contact,001,45,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8401,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8401/3: Apocrine adenocarcinoma,8401/3: Apocrine adenocarcinoma,Blank(s),Left - origin of primary,Localized,64 years,2,0,Counties in metropolitan areas ge 1 million pop
772,2071,Female,2014,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,56 years,2,0,Counties in metropolitan areas ge 1 million pop
778,2082,Female,2014,Alive at last contact,001,20,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,74 years,2,0,Counties in metropolitan areas ge 1 million pop
783,2090,Female,2014,2015,001,51,No radiation and/or cancer-directed surgery,Systemic therapy before surgery,Surgery performed,Yes,None/Unknown,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,69 years,2,0,Counties in metropolitan areas ge 1 million pop
787,2100,Female,2014,Alive at last contact,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8480,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8480/3: Mucinous adenocarcinoma,8480/3: Mucinous adenocarcinoma,Blank(s),Left - origin of primary,Localized,67 years,3,0,Counties in metropolitan areas ge 1 million pop
789,2107,Female,2014,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,66 years,3,0,Counties in metropolitan areas ge 1 million pop
796,2126,Female,2014,2015,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Unknown/unstaged,88 years,2,0,Counties in metropolitan areas ge 1 million pop
821,2199,Female,2014,2017,000,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,88 years,2,0,Counties in metropolitan areas ge 1 million pop
826,2219,Female,2014,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,71 years,2,0,Counties in metropolitan areas ge 1 million pop
827,2221,Female,2014,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,67 years,2,0,Counties in metropolitan areas ge 1 million pop
860,2311,Female,2014,Alive at last contact,001,49,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,44 years,2,0,Counties in metropolitan areas ge 1 million pop
891,2381,Female,2014,Alive at last contact,003,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,79 years,2,0,Counties in metropolitan areas ge 1 million pop
894,2385,Female,2014,2019,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Right - origin of primary,Localized,86 years,3,0,Counties in metropolitan areas ge 1 million pop
914,2417,Female,2014,2017,003,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Regional,81 years,4,0,Counties in metropolitan areas ge 1 million pop
927,2441,Female,2014,Alive at last contact,003,22,Radiation before and after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,71 years,2,0,Counties in metropolitan areas ge 1 million pop
928,2442,Female,2014,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8520,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8520/2: Lobular carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,55 years,2,0,Counties in metropolitan areas ge 1 million pop
938,2471,Female,2014,2018,000,0,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Distant,65 years,2,0,Counties in metropolitan areas ge 1 million pop
955,2515,Female,2014,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,76 years,3,0,Counties in metropolitan areas ge 1 million pop
979,2581,Female,2014,Alive at last contact,001,48,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,75 years,4,0,Counties in metropolitan areas ge 1 million pop
983,2597,Female,2014,2016,000,0,Radiation after surgery,Systemic therapy after surgery,Not recommended,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8140,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8140/3: Adenocarcinoma, NOS","8140/3: Adenocarcinoma, NOS",Blank(s),Right - origin of primary,Distant,63 years,2,0,Counties in metropolitan areas ge 1 million pop
998,2622,Female,2014,2016,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended but not performed, patient refused",No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,90+ years,3,0,Counties in metropolitan areas ge 1 million pop
999,2624,Female,2014,Alive at last contact,002,48,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,47 years,2,0,Counties in metropolitan areas ge 1 million pop
3,10,Female,2013,2015,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8010,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8010/3: Carcinoma, NOS","8010/3: Carcinoma, NOS",Blank(s),Right - origin of primary,Unknown/unstaged,44 years,3,0,Counties in metropolitan areas ge 1 million pop
5,12,Female,2013,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,Surgery both before and after systemic therapy,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,83 years,3,0,Counties in metropolitan areas ge 1 million pop
8,18,Female,2013,Alive at last contact,001,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,71 years,2,0,Counties in metropolitan areas ge 1 million pop
16,37,Female,2013,Alive at last contact,005,20,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8522/2: Intraductal and lobular in situ carcinoma,In situ,Blank(s),Left - origin of primary,In situ,57 years,2,0,Counties in metropolitan areas ge 1 million pop
64,121,Female,2013,2016,000,42,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,89 years,2,0,Counties in metropolitan areas ge 1 million pop
67,127,Female,2013,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,44 years,2,0,Counties in metropolitan areas ge 1 million pop
71,134,Female,2013,Alive at last contact,001,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,58 years,2,0,Counties in metropolitan areas ge 1 million pop
75,140,Female,2013,2016,000,80,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,88 years,2,0,Counties in metropolitan areas ge 1 million pop
82,157,Female,2013,2013,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,75 years,2,0,Counties in metropolitan areas ge 1 million pop
104,199,Female,2013,Alive at last contact,001,24,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,74 years,3,0,Counties in metropolitan areas ge 1 million pop
117,220,Female,2013,Alive at last contact,001,42,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,60 years,3,0,Counties in metropolitan areas ge 1 million pop
123,230,Female,2013,Alive at last contact,002,46,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,74 years,3,0,Counties in metropolitan areas ge 1 million pop
128,238,Female,2013,2019,002,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,78 years,2,0,Counties in metropolitan areas ge 1 million pop
130,249,Female,2013,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,90+ years,3,0,Counties in metropolitan areas ge 1 million pop
131,250,Female,2013,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,90+ years,3,0,Counties in metropolitan areas ge 1 million pop
133,252,Female,2013,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,54 years,2,0,Counties in metropolitan areas ge 1 million pop
139,270,Female,2013,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,70 years,2,0,Counties in metropolitan areas ge 1 million pop
159,312,Female,2013,Alive at last contact,010,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,66 years,2,0,Counties in metropolitan areas ge 1 million pop
161,314,Female,2013,Alive at last contact,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Unknown/unstaged,65 years,2,0,Counties in metropolitan areas ge 1 million pop
168,341,Female,2013,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8522,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,70 years,3,0,Counties in metropolitan areas ge 1 million pop
170,344,Female,2013,Alive at last contact,001,0,Radiation after surgery,Systemic therapy before surgery,Not recommended,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Regional,73 years,4,0,Counties in metropolitan areas ge 1 million pop
173,349,Female,2013,2014,001,40,No radiation and/or cancer-directed surgery,Systemic therapy before surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,74 years,3,0,Counties in metropolitan areas ge 1 million pop
176,362,Female,2013,Alive at last contact,001,51,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,76 years,3,0,Counties in metropolitan areas ge 1 million pop
180,375,Female,2013,2014,001,51,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Regional,77 years,5,0,Counties in metropolitan areas ge 1 million pop
190,418,Female,2013,2013,000,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8522,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Localized,88 years,2,0,Counties in metropolitan areas ge 1 million pop
196,430,Female,2013,2015,002,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,86 years,6,0,Counties in metropolitan areas ge 1 million pop
214,521,Female,2013,Alive at last contact,001,51,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,80 years,2,0,Counties in metropolitan areas ge 1 million pop
217,538,Female,2013,Alive at last contact,002,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,64 years,3,0,Counties in metropolitan areas ge 1 million pop
220,543,Female,2013,Alive at last contact,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Negative,Negative,Borderline/Unknown,In situ,In situ,Breast,8501,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8501/2: Comedocarcinoma, noninfiltrating",In situ,Blank(s),Left - origin of primary,In situ,89 years,3,0,Counties in metropolitan areas ge 1 million pop
222,545,Female,2013,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,69 years,2,0,Counties in metropolitan areas ge 1 million pop
224,552,Female,2013,Alive at last contact,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Negative,Negative,Borderline/Unknown,In situ,In situ,Breast,8501,Undifferentiated; anaplastic; Grade IV,Blank(s),Blank(s),Not classified by SEER or in situ,"8501/2: Comedocarcinoma, noninfiltrating",In situ,Blank(s),Right - origin of primary,In situ,80 years,2,0,Counties in metropolitan areas ge 1 million pop
245,646,Female,2013,Alive at last contact,000,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,76 years,2,0,Counties in metropolitan areas ge 1 million pop
246,647,Female,2013,2013,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Not recommended, contraindicated due to other cond; autopsy only (1973-2002)",No/Unknown,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8520,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Regional,90+ years,3,0,Counties in metropolitan areas ge 1 million pop
253,669,Female,2013,2014,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8480,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8480/3: Mucinous adenocarcinoma,8480/3: Mucinous adenocarcinoma,Blank(s),Right - origin of primary,Localized,75 years,3,0,Counties in metropolitan areas ge 1 million pop
257,677,Female,2013,Alive at last contact,002,52,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,77 years,2,0,Counties in metropolitan areas ge 1 million pop
275,728,Female,2013,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8520,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8520/2: Lobular carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,48 years,3,0,Counties in metropolitan areas ge 1 million pop
278,732,Female,2013,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,79 years,4,0,Counties in metropolitan areas ge 1 million pop
297,779,Female,2013,Alive at last contact,000,30,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8230,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8230/2: Ductal carcinoma in situ, solid type",In situ,Blank(s),Left - origin of primary,In situ,59 years,3,0,Counties in metropolitan areas ge 1 million pop
305,806,Female,2013,2018,000,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Well differentiated; Grade I,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,85 years,2,0,Counties in metropolitan areas ge 1 million pop
324,854,Female,2013,Alive at last contact,000,41,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,61 years,3,0,Counties in metropolitan areas ge 1 million pop
325,860,Female,2013,2017,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,75 years,2,0,Counties in metropolitan areas ge 1 million pop
336,884,Female,2013,2018,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,Yes,None/Unknown,Unknown,Positive,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8140,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8140/3: Adenocarcinoma, NOS","8140/3: Adenocarcinoma, NOS",Blank(s),Left - origin of primary,Distant,83 years,3,0,Counties in metropolitan areas ge 1 million pop
350,929,Female,2013,2013,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8010,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8010/3: Carcinoma, NOS","8010/3: Carcinoma, NOS",Blank(s),Left - origin of primary,Distant,57 years,2,0,Counties in metropolitan areas ge 1 million pop
356,941,Female,2013,2020,000,20,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8520,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8520/2: Lobular carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,73 years,3,0,Counties in metropolitan areas ge 1 million pop
390,1033,Female,2013,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,78 years,2,0,Counties in metropolitan areas ge 1 million pop
397,1050,Female,2013,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,66 years,3,0,Counties in metropolitan areas ge 1 million pop
403,1075,Female,2013,Alive at last contact,004,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,73 years,2,0,Counties in metropolitan areas ge 1 million pop
418,1118,Female,2013,Alive at last contact,001,42,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,64 years,3,0,Counties in metropolitan areas ge 1 million pop
420,1124,Female,2013,Alive at last contact,002,50,Radiation prior to surgery,Systemic therapy both before and after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,77 years,3,0,Counties in metropolitan areas ge 1 million pop
421,1125,Female,2013,Alive at last contact,002,22,Radiation after surgery,Systemic therapy both before and after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,77 years,3,0,Counties in metropolitan areas ge 1 million pop
424,1143,Female,2013,Alive at last contact,001,54,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,61 years,4,0,Counties in metropolitan areas ge 1 million pop
430,1160,Female,2013,Alive at last contact,001,20,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,47 years,2,0,Counties in metropolitan areas ge 1 million pop
431,1163,Female,2013,2018,000,51,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Regional,83 years,2,0,Counties in metropolitan areas ge 1 million pop
436,1176,Female,2013,Alive at last contact,001,40,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,56 years,3,0,Counties in metropolitan areas ge 1 million pop
452,1204,Female,2013,2020,001,40,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,82 years,3,0,Counties in metropolitan areas ge 1 million pop
458,1215,Female,2013,Alive at last contact,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,69 years,2,0,Counties in metropolitan areas ge 1 million pop
463,1227,Female,2013,2019,001,42,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,79 years,3,0,Counties in metropolitan areas ge 1 million pop
474,1285,Female,2013,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,78 years,2,0,Counties in metropolitan areas ge 1 million pop
490,1323,Female,2013,2019,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,70 years,2,0,Counties in metropolitan areas ge 1 million pop
522,1420,Female,2013,2020,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended but not performed, patient refused",No/Unknown,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,90+ years,4,0,Counties in metropolitan areas ge 1 million pop
523,1422,Female,2013,2017,000,51,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8046,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,8046/3: Non-small cell carcinoma,8046/3: Non-small cell carcinoma,Blank(s),Right - origin of primary,Localized,77 years,2,0,Counties in metropolitan areas ge 1 million pop
530,1435,Female,2013,Alive at last contact,001,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Left - origin of primary,Localized,83 years,3,0,Counties in metropolitan areas ge 1 million pop
532,1441,Female,2013,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Right - origin of primary,In situ,73 years,2,0,Counties in metropolitan areas ge 1 million pop
540,1466,Female,2013,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,70 years,2,0,Counties in metropolitan areas ge 1 million pop
554,1512,Female,2013,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,78 years,3,0,Counties in metropolitan areas ge 1 million pop
555,1513,Female,2013,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,In situ,In situ,Breast,8501,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8501/2: Comedocarcinoma, noninfiltrating",In situ,Blank(s),Right - origin of primary,In situ,78 years,3,0,Counties in metropolitan areas ge 1 million pop
565,1538,Female,2013,Alive at last contact,001,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Localized,75 years,2,0,Counties in metropolitan areas ge 1 million pop
567,1545,Female,2013,Alive at last contact,001,40,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8522,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Localized,67 years,2,0,Counties in metropolitan areas ge 1 million pop
595,1619,Female,2013,Alive at last contact,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8480,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,8480/3: Mucinous adenocarcinoma,8480/3: Mucinous adenocarcinoma,Blank(s),Right - origin of primary,Unknown/unstaged,66 years,2,0,Counties in metropolitan areas ge 1 million pop
596,1621,Female,2013,Alive at last contact,001,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,63 years,2,0,Counties in metropolitan areas ge 1 million pop
612,1662,Female,2013,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,61 years,3,0,Counties in metropolitan areas ge 1 million pop
628,1702,Female,2013,Alive at last contact,001,42,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,56 years,2,0,Counties in metropolitan areas ge 1 million pop
637,1723,Female,2013,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,69 years,2,0,Counties in metropolitan areas ge 1 million pop
639,1731,Female,2013,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8507,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8507/2: Intraductal micropapillary carcinoma,In situ,Blank(s),Left - origin of primary,In situ,70 years,2,0,Counties in metropolitan areas ge 1 million pop
647,1751,Female,2013,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,63 years,2,0,Counties in metropolitan areas ge 1 million pop
651,1763,Female,2013,2015,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,88 years,2,0,Counties in metropolitan areas ge 1 million pop
654,1769,Female,2013,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,63 years,3,0,Counties in metropolitan areas ge 1 million pop
687,1883,Female,2013,Alive at last contact,001,44,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,69 years,2,0,Counties in metropolitan areas ge 1 million pop
690,1891,Female,2013,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Regional,81 years,2,0,Counties in metropolitan areas ge 1 million pop
699,1906,Female,2013,Alive at last contact,001,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Recode not available,Recode not available,Recode not available,Recode not available,Malignant,Malignant,Breast,9020,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"9020/3: Phyllodes tumor, malignant","9020/3: Phyllodes tumor, malignant",Blank(s),Left - origin of primary,Localized,83 years,2,0,Counties in metropolitan areas ge 1 million pop
703,1917,Female,2013,Alive at last contact,002,53,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,49 years,2,0,Counties in metropolitan areas ge 1 million pop
708,1932,Female,2013,Alive at last contact,002,20,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,75 years,3,0,Counties in metropolitan areas ge 1 million pop
735,1992,Female,2013,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,52 years,5,0,Counties in metropolitan areas ge 1 million pop
752,2025,Female,2013,Alive at last contact,001,40,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,61 years,2,0,Counties in metropolitan areas ge 1 million pop
782,2089,Female,2013,2016,001,42,No radiation and/or cancer-directed surgery,Systemic therapy before surgery,Surgery performed,Yes,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,71 years,4,0,Counties in metropolitan areas ge 1 million pop
790,2114,Female,2013,Alive at last contact,000,51,No radiation and/or cancer-directed surgery,Systemic therapy both before and after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8480,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8480/3: Mucinous adenocarcinoma,8480/3: Mucinous adenocarcinoma,Blank(s),Left - origin of primary,Localized,85 years,4,0,Counties in metropolitan areas ge 1 million pop
798,2132,Female,2013,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,69 years,4,0,Counties in metropolitan areas ge 1 million pop
802,2137,Female,2013,2020,002,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,80 years,2,0,Counties in metropolitan areas ge 1 million pop
803,2139,Female,2013,Alive at last contact,000,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,72 years,2,0,Counties in metropolitan areas ge 1 million pop
804,2143,Female,2013,Alive at last contact,001,40,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Left - origin of primary,Regional,81 years,2,0,Counties in metropolitan areas ge 1 million pop
807,2146,Female,2013,Alive at last contact,001,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,79 years,6,0,Counties in metropolitan areas ge 1 million pop
828,2225,Female,2013,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,66 years,2,0,Counties in metropolitan areas ge 1 million pop
835,2245,Female,2013,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Right - origin of primary,Localized,78 years,2,0,Counties in metropolitan areas ge 1 million pop
840,2259,Female,2013,2018,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,68 years,3,0,Counties in metropolitan areas ge 1 million pop
847,2270,Female,2013,Alive at last contact,003,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,65 years,2,0,Counties in metropolitan areas ge 1 million pop
862,2319,Female,2013,Alive at last contact,000,45,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,72 years,3,0,Counties in metropolitan areas ge 1 million pop
867,2327,Female,2013,Alive at last contact,003,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,49 years,3,0,Counties in metropolitan areas ge 1 million pop
874,2345,Female,2013,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,76 years,3,0,Counties in metropolitan areas ge 1 million pop
876,2352,Female,2013,Alive at last contact,001,49,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,60 years,2,0,Counties in metropolitan areas ge 1 million pop
883,2361,Female,2013,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,62 years,3,0,Counties in metropolitan areas ge 1 million pop
932,2457,Female,2013,Alive at last contact,002,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8501,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8501/2: Comedocarcinoma, noninfiltrating",In situ,Blank(s),Left - origin of primary,In situ,75 years,3,0,Counties in metropolitan areas ge 1 million pop
935,2467,Female,2013,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,86 years,3,0,Counties in metropolitan areas ge 1 million pop
936,2468,Female,2013,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,86 years,3,0,Counties in metropolitan areas ge 1 million pop
943,2484,Female,2013,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,84 years,3,0,Counties in metropolitan areas ge 1 million pop
948,2498,Female,2013,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,62 years,2,0,Counties in metropolitan areas ge 1 million pop
950,2501,Female,2013,2019,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,Unknown,Negative,Negative,Borderline/Unknown,In situ,In situ,Breast,8501,Undifferentiated; anaplastic; Grade IV,Blank(s),Blank(s),Not classified by SEER or in situ,"8501/2: Comedocarcinoma, noninfiltrating",In situ,Blank(s),Left - origin of primary,In situ,85 years,3,0,Counties in metropolitan areas ge 1 million pop
985,2599,Female,2013,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,75 years,3,0,Counties in metropolitan areas ge 1 million pop
987,2602,Female,2013,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,81 years,2,0,Counties in metropolitan areas ge 1 million pop
988,2603,Female,2013,Alive at last contact,005,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Negative,Negative,Borderline/Unknown,In situ,In situ,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,72 years,2,0,Counties in metropolitan areas ge 1 million pop
997,2620,Female,2013,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,45 years,2,0,Counties in metropolitan areas ge 1 million pop
4,11,Female,2012,Alive at last contact,004,22,No radiation and/or cancer-directed surgery,Systemic therapy before surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,82 years,3,0,Counties in metropolitan areas ge 1 million pop
28,56,Female,2012,Alive at last contact,000,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,56 years,2,0,Counties in metropolitan areas ge 1 million pop
42,84,Female,2012,2016,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8480,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8480/3: Mucinous adenocarcinoma,8480/3: Mucinous adenocarcinoma,Blank(s),Left - origin of primary,Unknown/unstaged,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
55,101,Female,2012,2012,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
61,116,Female,2012,Alive at last contact,000,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,71 years,2,0,Counties in metropolitan areas ge 1 million pop
65,122,Female,2012,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Right - origin of primary,In situ,60 years,2,0,Counties in metropolitan areas ge 1 million pop
77,146,Female,2012,2015,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Not recommended, contraindicated due to other cond; autopsy only (1973-2002)",No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,82 years,2,0,Counties in metropolitan areas ge 1 million pop
99,192,Female,2012,Alive at last contact,001,40,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8523,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Left - origin of primary,Regional,82 years,3,0,Counties in metropolitan areas ge 1 million pop
106,203,Female,2012,2014,005,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8046,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,8046/3: Non-small cell carcinoma,8046/3: Non-small cell carcinoma,Blank(s),"Paired site, but no information concerning laterality",Distant,86 years,3,0,Counties in metropolitan areas ge 1 million pop
108,206,Female,2012,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,68 years,4,0,Counties in metropolitan areas ge 1 million pop
118,222,Female,2012,Alive at last contact,004,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Right - origin of primary,Localized,68 years,4,0,Counties in metropolitan areas ge 1 million pop
125,233,Female,2012,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,78 years,2,0,Counties in metropolitan areas ge 1 million pop
129,248,Female,2012,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,74 years,2,0,Counties in metropolitan areas ge 1 million pop
132,251,Female,2012,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8504,Well differentiated; Grade I,Blank(s),Blank(s),Not classified by SEER or in situ,8504/2: Noninfiltrating intracystic carcinoma,In situ,Blank(s),Left - origin of primary,In situ,69 years,2,0,Counties in metropolitan areas ge 1 million pop
154,297,Female,2012,2014,001,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Right - origin of primary,Localized,88 years,2,0,Counties in metropolitan areas ge 1 million pop
160,313,Female,2012,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,77 years,2,0,Counties in metropolitan areas ge 1 million pop
164,326,Female,2012,Alive at last contact,002,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Negative,Negative,Borderline/Unknown,In situ,In situ,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,58 years,3,0,Counties in metropolitan areas ge 1 million pop
169,343,Female,2012,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,71 years,3,0,Counties in metropolitan areas ge 1 million pop
182,380,Female,2012,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,54 years,3,0,Counties in metropolitan areas ge 1 million pop
183,381,Female,2012,Alive at last contact,006,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8201,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8201/2: Cribriform carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,54 years,3,0,Counties in metropolitan areas ge 1 million pop
188,403,Female,2012,2013,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Regional,90+ years,3,0,Counties in metropolitan areas ge 1 million pop
192,421,Female,2012,2015,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,79 years,4,0,Counties in metropolitan areas ge 1 million pop
198,438,Female,2012,2012,001,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Left - origin of primary,Distant,85 years,2,0,Counties in metropolitan areas ge 1 million pop
203,466,Female,2012,2016,002,40,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,85 years,2,0,Counties in metropolitan areas ge 1 million pop
210,496,Female,2012,2017,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,61 years,3,0,Counties in metropolitan areas ge 1 million pop
228,569,Female,2012,2016,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended but not performed, patient refused",No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,88 years,3,0,Counties in metropolitan areas ge 1 million pop
240,618,Female,2012,2015,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,84 years,3,0,Counties in metropolitan areas ge 1 million pop
249,656,Female,2012,Alive at last contact,000,41,Radiation after surgery,Systemic therapy both before and after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Regional,67 years,2,0,Counties in metropolitan areas ge 1 million pop
258,688,Female,2012,2012,Blank(s),99,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Unknown; death certificate; or autopsy only (2003+),No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8000,Unknown,Blank(s),Blank(s),XIIb Other unspecified malignant tumors,"8000/3: Neoplasm, malignant","8000/3: Neoplasm, malignant",Blank(s),"Paired site, but no information concerning laterality",Unknown/unstaged,90+ years,3,0,Counties in metropolitan areas ge 1 million pop
266,702,Female,2012,2018,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,85 years,3,0,Counties in metropolitan areas ge 1 million pop
267,704,Female,2012,2016,000,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Negative,Negative,Borderline/Unknown,In situ,In situ,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,68 years,6,0,Counties in metropolitan areas ge 1 million pop
277,731,Female,2012,2016,003,20,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,89 years,2,0,Counties in metropolitan areas ge 1 million pop
288,750,Female,2012,Alive at last contact,000,41,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,75 years,3,0,Counties in metropolitan areas ge 1 million pop
299,786,Female,2012,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8520,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8520/2: Lobular carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,67 years,3,0,Counties in metropolitan areas ge 1 million pop
301,791,Female,2012,2015,003,40,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
338,888,Female,2012,2017,001,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Distant,66 years,3,0,Counties in metropolitan areas ge 1 million pop
340,892,Female,2012,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,76 years,2,0,Counties in metropolitan areas ge 1 million pop
342,910,Female,2012,Alive at last contact,003,75,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,61 years,3,0,Counties in metropolitan areas ge 1 million pop
364,971,Female,2012,Alive at last contact,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Radioactive implants (includes brachytherapy) (1988+),HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,70 years,2,0,Counties in metropolitan areas ge 1 million pop
379,1008,Female,2012,Alive at last contact,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,80 years,3,0,Counties in metropolitan areas ge 1 million pop
445,1195,Female,2012,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,86 years,4,0,Counties in metropolitan areas ge 1 million pop
454,1208,Female,2012,2020,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,66 years,3,0,Counties in metropolitan areas ge 1 million pop
479,1299,Female,2012,Alive at last contact,001,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,56 years,2,0,Counties in metropolitan areas ge 1 million pop
481,1306,Female,2012,Alive at last contact,001,45,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,67 years,3,0,Counties in metropolitan areas ge 1 million pop
482,1309,Female,2012,2016,002,44,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,51 years,3,0,Counties in metropolitan areas ge 1 million pop
484,1312,Female,2012,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,78 years,2,0,Counties in metropolitan areas ge 1 million pop
502,1357,Female,2012,Alive at last contact,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8230,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8230/2: Ductal carcinoma in situ, solid type",In situ,Blank(s),Right - origin of primary,In situ,78 years,2,0,Counties in metropolitan areas ge 1 million pop
516,1390,Female,2012,2020,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,84 years,3,0,Counties in metropolitan areas ge 1 million pop
520,1408,Female,2012,Alive at last contact,001,23,Intraoperative rad with other rad before/after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,72 years,3,0,Counties in metropolitan areas ge 1 million pop
521,1418,Female,2012,2015,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
541,1472,Female,2012,2013,000,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,61 years,2,0,Counties in metropolitan areas ge 1 million pop
544,1483,Female,2012,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,69 years,2,0,Counties in metropolitan areas ge 1 million pop
545,1486,Female,2012,2015,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Distant,70 years,2,0,Counties in metropolitan areas ge 1 million pop
563,1536,Female,2012,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,52 years,2,0,Counties in metropolitan areas ge 1 million pop
589,1606,Female,2012,2018,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Negative,Negative,Borderline/Unknown,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,81 years,5,0,Counties in metropolitan areas ge 1 million pop
591,1610,Female,2012,Alive at last contact,001,45,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,74 years,2,0,Counties in metropolitan areas ge 1 million pop
593,1616,Female,2012,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8520/2: Lobular carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,71 years,2,0,Counties in metropolitan areas ge 1 million pop
602,1633,Female,2012,2015,000,0,Radiation after surgery,Systemic therapy after surgery,"Recommended, unknown if performed",No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,65 years,2,0,Counties in metropolitan areas ge 1 million pop
653,1768,Female,2012,Alive at last contact,006,40,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8050,Well differentiated; Grade I,Blank(s),Blank(s),Not classified by SEER or in situ,8050/2: Papillary carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,63 years,3,0,Counties in metropolitan areas ge 1 million pop
663,1805,Female,2012,2019,000,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,85 years,3,0,Counties in metropolitan areas ge 1 million pop
665,1813,Female,2012,2013,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended, unknown if performed",No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,78 years,2,0,Counties in metropolitan areas ge 1 million pop
666,1816,Female,2012,Alive at last contact,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8201,Well differentiated; Grade I,Blank(s),Blank(s),Not classified by SEER or in situ,8201/2: Cribriform carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,74 years,2,0,Counties in metropolitan areas ge 1 million pop
676,1854,Female,2012,Alive at last contact,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8000,Unknown,Blank(s),Blank(s),XIIb Other unspecified malignant tumors,"8000/3: Neoplasm, malignant","8000/3: Neoplasm, malignant",Blank(s),"Paired site, but no information concerning laterality",Localized,73 years,4,0,Counties in metropolitan areas ge 1 million pop
678,1856,Female,2012,2020,002,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,66 years,3,0,Counties in metropolitan areas ge 1 million pop
679,1863,Female,2012,2016,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,88 years,2,0,Counties in metropolitan areas ge 1 million pop
726,1971,Female,2012,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,69 years,2,0,Counties in metropolitan areas ge 1 million pop
729,1978,Female,2012,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8201,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8201/2: Cribriform carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,65 years,2,0,Counties in metropolitan areas ge 1 million pop
733,1984,Female,2012,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Negative,Negative,Borderline/Unknown,In situ,In situ,Breast,8501,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8501/2: Comedocarcinoma, noninfiltrating",In situ,Blank(s),Left - origin of primary,In situ,68 years,2,0,Counties in metropolitan areas ge 1 million pop
736,1993,Female,2012,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8500,Undifferentiated; anaplastic; Grade IV,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,75 years,2,0,Counties in metropolitan areas ge 1 million pop
740,2004,Female,2012,2013,002,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,82 years,3,0,Counties in metropolitan areas ge 1 million pop
741,2005,Female,2012,2013,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,83 years,3,0,Counties in metropolitan areas ge 1 million pop
745,2016,Female,2012,2020,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8500,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,76 years,2,0,Counties in metropolitan areas ge 1 million pop
759,2047,Female,2012,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8524,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8524/3: Infiltrating lobular mixed with other types of carcinoma,8524/3: Infiltrating lobular mixed with other types of carcinoma,Blank(s),Left - origin of primary,Localized,68 years,5,0,Counties in metropolitan areas ge 1 million pop
760,2048,Female,2012,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,68 years,5,0,Counties in metropolitan areas ge 1 million pop
766,2058,Female,2012,Alive at last contact,001,22,Intraoperative rad with other rad before/after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,67 years,2,0,Counties in metropolitan areas ge 1 million pop
794,2122,Female,2012,Alive at last contact,001,24,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,73 years,3,0,Counties in metropolitan areas ge 1 million pop
797,2129,Female,2012,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8480,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,8480/3: Mucinous adenocarcinoma,8480/3: Mucinous adenocarcinoma,Blank(s),Left - origin of primary,Localized,82 years,2,0,Counties in metropolitan areas ge 1 million pop
800,2134,Female,2012,2013,000,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended, unknown if performed",No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,80 years,2,0,Counties in metropolitan areas ge 1 million pop
820,2186,Female,2012,2015,001,51,Radiation after surgery,Systemic therapy before surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,63 years,2,0,Counties in metropolitan areas ge 1 million pop
823,2210,Female,2012,2019,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,81 years,2,0,Counties in metropolitan areas ge 1 million pop
829,2227,Female,2012,Alive at last contact,001,42,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,77 years,2,0,Counties in metropolitan areas ge 1 million pop
831,2232,Female,2012,Alive at last contact,000,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8201,Well differentiated; Grade I,Blank(s),Blank(s),Not classified by SEER or in situ,8201/2: Cribriform carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,47 years,2,0,Counties in metropolitan areas ge 1 million pop
834,2240,Female,2012,Alive at last contact,002,24,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,66 years,3,0,Counties in metropolitan areas ge 1 million pop
866,2324,Female,2012,Alive at last contact,000,47,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,67 years,3,0,Counties in metropolitan areas ge 1 million pop
871,2339,Female,2012,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Radioactive implants (includes brachytherapy) (1988+),Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,58 years,3,0,Counties in metropolitan areas ge 1 million pop
872,2340,Female,2012,Alive at last contact,000,47,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,58 years,3,0,Counties in metropolitan areas ge 1 million pop
873,2344,Female,2012,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,81 years,2,0,Counties in metropolitan areas ge 1 million pop
877,2353,Female,2012,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Negative,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,58 years,3,0,Counties in metropolitan areas ge 1 million pop
879,2356,Female,2012,2020,001,52,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Regional,47 years,2,0,Counties in metropolitan areas ge 1 million pop
884,2362,Female,2012,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,70 years,2,0,Counties in metropolitan areas ge 1 million pop
901,2394,Female,2012,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,85 years,3,0,Counties in metropolitan areas ge 1 million pop
903,2396,Female,2012,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,79 years,2,0,Counties in metropolitan areas ge 1 million pop
905,2398,Female,2012,Alive at last contact,002,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Left - origin of primary,Localized,73 years,3,0,Counties in metropolitan areas ge 1 million pop
907,2403,Female,2012,Alive at last contact,003,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Negative,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,53 years,2,0,Counties in metropolitan areas ge 1 million pop
915,2419,Female,2012,2015,001,50,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,88 years,2,0,Counties in metropolitan areas ge 1 million pop
921,2433,Female,2012,2014,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,87 years,4,0,Counties in metropolitan areas ge 1 million pop
931,2454,Female,2012,Alive at last contact,001,23,Radiation after surgery,Systemic therapy before surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8140,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8140/3: Adenocarcinoma, NOS","8140/3: Adenocarcinoma, NOS",Blank(s),Right - origin of primary,Regional,61 years,2,0,Counties in metropolitan areas ge 1 million pop
939,2478,Female,2012,Alive at last contact,002,40,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,76 years,2,0,Counties in metropolitan areas ge 1 million pop
965,2540,Female,2012,Alive at last contact,002,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,Beam radiation,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,73 years,2,0,Counties in metropolitan areas ge 1 million pop
972,2558,Female,2012,2016,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,54 years,3,0,Counties in metropolitan areas ge 1 million pop
982,2596,Female,2012,2013,002,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Recommended, unknown if performed",Yes,None/Unknown,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,86 years,3,0,Counties in metropolitan areas ge 1 million pop
989,2604,Female,2012,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,65 years,2,0,Counties in metropolitan areas ge 1 million pop
7,16,Female,2011,2012,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8010,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8010/3: Carcinoma, NOS","8010/3: Carcinoma, NOS",Blank(s),Left - origin of primary,Regional,85 years,2,0,Counties in metropolitan areas ge 1 million pop
18,40,Female,2011,Alive at last contact,000,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8230,Undifferentiated; anaplastic; Grade IV,Blank(s),Blank(s),Not classified by SEER or in situ,"8230/2: Ductal carcinoma in situ, solid type",In situ,Blank(s),Right - origin of primary,In situ,58 years,2,0,Counties in metropolitan areas ge 1 million pop
21,46,Female,2011,Alive at last contact,003,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8230,Undifferentiated; anaplastic; Grade IV,Blank(s),Blank(s),Not classified by SEER or in situ,"8230/2: Ductal carcinoma in situ, solid type",In situ,Blank(s),Left - origin of primary,In situ,58 years,4,0,Counties in metropolitan areas ge 1 million pop
23,50,Female,2011,Alive at last contact,001,45,No radiation and/or cancer-directed surgery,Systemic therapy both before and after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,52 years,2,0,Counties in metropolitan areas ge 1 million pop
37,69,Female,2011,2013,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8010,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8010/3: Carcinoma, NOS","8010/3: Carcinoma, NOS",Blank(s),Right - origin of primary,Distant,76 years,2,0,Counties in metropolitan areas ge 1 million pop
48,93,Female,2011,2020,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,55 years,2,0,Counties in metropolitan areas ge 1 million pop
51,96,Female,2011,Alive at last contact,003,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,78 years,2,0,Counties in metropolitan areas ge 1 million pop
63,120,Female,2011,Alive at last contact,002,46,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Left - origin of primary,Localized,62 years,2,0,Counties in metropolitan areas ge 1 million pop
72,136,Female,2011,Alive at last contact,003,49,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,59 years,3,0,Counties in metropolitan areas ge 1 million pop
73,137,Female,2011,2014,002,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
78,147,Female,2011,Alive at last contact,001,42,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,63 years,3,0,Counties in metropolitan areas ge 1 million pop
79,149,Female,2011,Alive at last contact,001,24,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,52 years,3,0,Counties in metropolitan areas ge 1 million pop
84,159,Female,2011,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,78 years,3,0,Counties in metropolitan areas ge 1 million pop
92,182,Female,2011,Alive at last contact,001,49,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2+,Positive,Negative,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,55 years,2,0,Counties in metropolitan areas ge 1 million pop
95,187,Female,2011,Alive at last contact,001,41,Intraoperative rad with other rad before/after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,42 years,2,0,Counties in metropolitan areas ge 1 million pop
136,264,Female,2011,Alive at last contact,001,44,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8480,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8480/3: Mucinous adenocarcinoma,8480/3: Mucinous adenocarcinoma,Blank(s),Right - origin of primary,Localized,68 years,2,0,Counties in metropolitan areas ge 1 million pop
146,279,Female,2011,2017,002,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,73 years,3,0,Counties in metropolitan areas ge 1 million pop
147,280,Female,2011,2017,000,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8140,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8140/3: Adenocarcinoma, NOS","8140/3: Adenocarcinoma, NOS",Blank(s),Left - origin of primary,Regional,74 years,3,0,Counties in metropolitan areas ge 1 million pop
171,346,Female,2011,2019,002,21,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,90+ years,3,0,Counties in metropolitan areas ge 1 million pop
184,389,Female,2011,2020,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8503,Well differentiated; Grade I,Blank(s),Blank(s),Not classified by SEER or in situ,8503/2: Noninfiltrating intraductal papillary adenocarcinoma,In situ,Blank(s),Right - origin of primary,In situ,83 years,3,0,Counties in metropolitan areas ge 1 million pop
195,429,Female,2011,2015,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,84 years,6,0,Counties in metropolitan areas ge 1 million pop
207,480,Female,2011,2018,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,87 years,4,0,Counties in metropolitan areas ge 1 million pop
225,562,Female,2011,2020,001,40,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Localized,83 years,2,0,Counties in metropolitan areas ge 1 million pop
226,563,Female,2011,2015,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8522,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Localized,79 years,3,1,Counties in metropolitan areas ge 1 million pop
230,585,Female,2011,Alive at last contact,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Right - origin of primary,In situ,77 years,3,0,Counties in metropolitan areas ge 1 million pop
233,594,Female,2011,Alive at last contact,001,41,Radiation after surgery,Systemic therapy both before and after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,44 years,3,1,Counties in metropolitan areas ge 1 million pop
236,607,Female,2011,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,66 years,3,0,Counties in metropolitan areas ge 1 million pop
242,623,Female,2011,Alive at last contact,002,23,Intraoperative radiation,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,65 years,2,0,Counties in metropolitan areas ge 1 million pop
259,690,Female,2011,Alive at last contact,002,20,Radiation after surgery,Systemic therapy both before and after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,70 years,2,0,Counties in metropolitan areas ge 1 million pop
264,696,Female,2011,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,74 years,2,0,Counties in metropolitan areas ge 1 million pop
273,722,Female,2011,Alive at last contact,001,40,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,72 years,2,0,Counties in metropolitan areas ge 1 million pop
284,745,Female,2011,Alive at last contact,000,40,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,71 years,3,0,Counties in metropolitan areas ge 1 million pop
289,753,Female,2011,2018,000,23,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Right - origin of primary,Localized,79 years,3,1,Counties in metropolitan areas ge 1 million pop
295,769,Female,2011,Alive at last contact,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Radioactive implants (includes brachytherapy) (1988+),Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8201,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8201/2: Cribriform carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,68 years,4,0,Counties in metropolitan areas ge 1 million pop
296,774,Female,2011,Alive at last contact,000,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,62 years,2,0,Counties in metropolitan areas ge 1 million pop
300,788,Female,2011,Alive at last contact,003,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Right - origin of primary,In situ,62 years,2,0,Counties in metropolitan areas ge 1 million pop
302,793,Female,2011,Alive at last contact,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,85 years,2,0,Counties in metropolitan areas ge 1 million pop
315,836,Female,2011,Alive at last contact,001,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,71 years,2,0,Counties in metropolitan areas ge 1 million pop
317,839,Female,2011,2016,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8211,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8211/3: Tubular adenocarcinoma,8211/3: Tubular adenocarcinoma,Blank(s),Left - origin of primary,Distant,76 years,3,0,Counties in metropolitan areas ge 1 million pop
322,848,Female,2011,Alive at last contact,001,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Left - origin of primary,Regional,68 years,2,0,Counties in metropolitan areas ge 1 million pop
355,938,Female,2011,2020,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,76 years,2,0,Counties in metropolitan areas ge 1 million pop
370,990,Female,2011,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,67 years,3,0,Counties in metropolitan areas ge 1 million pop
375,1002,Female,2011,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8522/2: Intraductal and lobular in situ carcinoma,In situ,Blank(s),Right - origin of primary,In situ,82 years,2,0,Counties in metropolitan areas ge 1 million pop
384,1016,Female,2011,2015,001,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,85 years,2,0,Counties in metropolitan areas ge 1 million pop
385,1017,Female,2011,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Right - origin of primary,In situ,77 years,2,0,Counties in metropolitan areas ge 1 million pop
393,1040,Female,2011,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,79 years,2,0,Counties in metropolitan areas ge 1 million pop
394,1042,Female,2011,2014,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,75 years,2,0,Counties in metropolitan areas ge 1 million pop
400,1070,Female,2011,Alive at last contact,004,45,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8501,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8501/2: Comedocarcinoma, noninfiltrating",In situ,Blank(s),Left - origin of primary,In situ,64 years,3,0,Counties in metropolitan areas ge 1 million pop
401,1071,Female,2011,Alive at last contact,001,46,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,72 years,2,0,Counties in metropolitan areas ge 1 million pop
411,1105,Female,2011,2013,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,82 years,3,0,Counties in metropolitan areas ge 1 million pop
413,1113,Female,2011,Alive at last contact,001,0,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Not recommended,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,61 years,3,0,Counties in metropolitan areas ge 1 million pop
414,1114,Female,2011,Alive at last contact,000,22,Radiation after surgery,Systemic therapy before surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,61 years,3,0,Counties in metropolitan areas ge 1 million pop
428,1158,Female,2011,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Regional,64 years,2,0,Counties in metropolitan areas ge 1 million pop
433,1165,Female,2011,2016,000,0,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,84 years,2,0,Counties in metropolitan areas ge 1 million pop
434,1166,Female,2011,Alive at last contact,002,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,74 years,3,0,Counties in metropolitan areas ge 1 million pop
447,1198,Female,2011,2013,002,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
449,1201,Female,2011,2016,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,62 years,2,0,Counties in metropolitan areas ge 1 million pop
451,1203,Female,2011,2020,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Undifferentiated; anaplastic; Grade IV,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,80 years,3,0,Counties in metropolitan areas ge 1 million pop
462,1225,Female,2011,Alive at last contact,001,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Negative,Negative,Borderline/Unknown,In situ,In situ,Breast,8523,Undifferentiated; anaplastic; Grade IV,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,66 years,2,0,Counties in metropolitan areas ge 1 million pop
464,1228,Female,2011,2018,000,23,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Well differentiated; Grade I,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,84 years,2,0,Counties in metropolitan areas ge 1 million pop
476,1290,Female,2011,Alive at last contact,002,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Undifferentiated; anaplastic; Grade IV,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Right - origin of primary,In situ,57 years,2,0,Counties in metropolitan areas ge 1 million pop
478,1297,Female,2011,2014,001,40,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,66 years,5,0,Counties in metropolitan areas ge 1 million pop
480,1304,Female,2011,Alive at last contact,000,42,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,70 years,3,0,Counties in metropolitan areas ge 1 million pop
486,1315,Female,2011,2013,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Distant,64 years,2,0,Counties in metropolitan areas ge 1 million pop
494,1332,Female,2011,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,81 years,2,0,Counties in metropolitan areas ge 1 million pop
503,1361,Female,2011,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,60 years,2,0,Counties in metropolitan areas ge 1 million pop
517,1392,Female,2011,Alive at last contact,001,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,75 years,2,0,Counties in metropolitan areas ge 1 million pop
529,1434,Female,2011,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,72 years,2,0,Counties in metropolitan areas ge 1 million pop
531,1438,Female,2011,2011,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,74 years,2,0,Counties in metropolitan areas ge 1 million pop
535,1451,Female,2011,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,74 years,2,0,Counties in metropolitan areas ge 1 million pop
538,1460,Female,2011,Alive at last contact,003,80,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,74 years,3,0,Counties in metropolitan areas ge 1 million pop
566,1542,Female,2011,2016,000,41,No radiation and/or cancer-directed surgery,Intraop systemic rx & oth systemic rx before/after surg,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Undifferentiated; anaplastic; Grade IV,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,58 years,3,0,Counties in metropolitan areas ge 1 million pop
588,1601,Female,2011,2019,004,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,77 years,3,0,Counties in metropolitan areas ge 1 million pop
610,1658,Female,2011,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,76 years,2,1,Counties in metropolitan areas ge 1 million pop
623,1685,Female,2011,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,61 years,2,0,Counties in metropolitan areas ge 1 million pop
626,1692,Female,2011,2014,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,90+ years,3,0,Counties in metropolitan areas ge 1 million pop
646,1749,Female,2011,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Right - origin of primary,In situ,78 years,3,0,Counties in metropolitan areas ge 1 million pop
657,1781,Female,2011,2015,001,42,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8522,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,43 years,3,0,Counties in metropolitan areas ge 1 million pop
659,1788,Female,2011,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,71 years,2,0,Counties in metropolitan areas ge 1 million pop
662,1804,Female,2011,2019,000,21,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,84 years,3,0,Counties in metropolitan areas ge 1 million pop
667,1819,Female,2011,Alive at last contact,001,43,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Recode not available,Recode not available,Recode not available,Recode not available,Malignant,Malignant,Breast,9120,Well differentiated; Grade I,Blank(s),Blank(s),IXd8 Blood vessel tumors,9120/3: Hemangiosarcoma,9120/3: Hemangiosarcoma,Blank(s),Left - origin of primary,Regional,82 years,2,0,Counties in metropolitan areas ge 1 million pop
684,1877,Female,2011,2012,003,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Radioactive implants (includes brachytherapy) (1988+),HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,53 years,2,0,Counties in metropolitan areas ge 1 million pop
698,1905,Female,2011,2016,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
702,1916,Female,2011,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8520,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8520/2: Lobular carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,75 years,4,0,Counties in metropolitan areas ge 1 million pop
705,1927,Female,2011,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,69 years,3,1,Counties in metropolitan areas ge 1 million pop
711,1941,Female,2011,Alive at last contact,001,22,Intraoperative radiation,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,63 years,2,0,Counties in metropolitan areas ge 1 million pop
724,1965,Female,2011,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,62 years,5,0,Counties in metropolitan areas ge 1 million pop
731,1982,Female,2011,Alive at last contact,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,68 years,3,0,Counties in metropolitan areas ge 1 million pop
746,2017,Female,2011,Alive at last contact,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,74 years,2,0,Counties in metropolitan areas ge 1 million pop
747,2018,Female,2011,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Left - origin of primary,Localized,80 years,6,0,Counties in metropolitan areas ge 1 million pop
765,2055,Female,2011,Alive at last contact,001,51,Radiation after surgery,Systemic therapy before surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8530,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8530/3: Inflammatory carcinoma,8530/3: Inflammatory carcinoma,Blank(s),Left - origin of primary,Regional,59 years,2,0,Counties in metropolitan areas ge 1 million pop
774,2073,Female,2011,2020,000,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,55 years,5,0,Counties in metropolitan areas ge 1 million pop
779,2083,Female,2011,Alive at last contact,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8501,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8501/2: Comedocarcinoma, noninfiltrating",In situ,Blank(s),Left - origin of primary,In situ,49 years,2,0,Counties in metropolitan areas ge 1 million pop
788,2102,Female,2011,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Right - origin of primary,In situ,46 years,2,0,Counties in metropolitan areas ge 1 million pop
809,2149,Female,2011,Alive at last contact,001,51,Radiation after surgery,Systemic therapy before surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,54 years,2,0,Counties in metropolitan areas ge 1 million pop
816,2176,Female,2011,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8501,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8501/2: Comedocarcinoma, noninfiltrating",In situ,Blank(s),Right - origin of primary,In situ,50 years,2,0,Counties in metropolitan areas ge 1 million pop
825,2218,Female,2011,2016,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,73 years,5,0,Counties in metropolitan areas ge 1 million pop
843,2264,Female,2011,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,66 years,4,0,Counties in metropolitan areas ge 1 million pop
850,2280,Female,2011,Alive at last contact,001,40,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,73 years,2,0,Counties in metropolitan areas ge 1 million pop
852,2291,Female,2011,2011,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Distant,73 years,3,0,Counties in metropolitan areas ge 1 million pop
870,2334,Female,2011,2015,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8507,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8507/3: Ductal carcinoma, micropapillary","8507/3: Ductal carcinoma, micropapillary",Blank(s),Right - origin of primary,Localized,89 years,2,0,Counties in metropolitan areas ge 1 million pop
878,2355,Female,2011,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,65 years,2,0,Counties in metropolitan areas ge 1 million pop
882,2359,Female,2011,Alive at last contact,000,40,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,67 years,3,0,Counties in metropolitan areas ge 1 million pop
908,2404,Female,2011,2015,002,55,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,64 years,2,0,Counties in metropolitan areas ge 1 million pop
912,2411,Female,2011,2019,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,64 years,3,0,Counties in metropolitan areas ge 1 million pop
917,2423,Female,2011,Alive at last contact,000,50,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8010,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8010/3: Carcinoma, NOS","8010/3: Carcinoma, NOS",Blank(s),Left - origin of primary,Regional,72 years,3,0,Counties in metropolitan areas ge 1 million pop
937,2469,Female,2011,Alive at last contact,001,42,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Regional,73 years,2,0,Counties in metropolitan areas ge 1 million pop
941,2481,Female,2011,Alive at last contact,001,42,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,62 years,2,0,Counties in metropolitan areas ge 1 million pop
945,2490,Female,2011,2015,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,75 years,4,0,Counties in metropolitan areas ge 1 million pop
947,2496,Female,2011,Alive at last contact,001,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Radioactive implants (includes brachytherapy) (1988+),Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8500,Undifferentiated; anaplastic; Grade IV,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Right - origin of primary,In situ,61 years,2,0,Counties in metropolitan areas ge 1 million pop
971,2557,Female,2011,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,79 years,2,0,Counties in metropolitan areas ge 1 million pop
978,2580,Female,2011,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Radioactive implants (includes brachytherapy) (1988+),HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,72 years,4,0,Counties in metropolitan areas ge 1 million pop
986,2601,Female,2011,2013,013,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8010,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8010/3: Carcinoma, NOS","8010/3: Carcinoma, NOS",Blank(s),"Paired site, but no information concerning laterality",Distant,64 years,2,0,Counties in metropolitan areas ge 1 million pop
0,2,Female,2010,2011,002,80,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,70 years,3,0,Counties in metropolitan areas ge 1 million pop
14,32,Female,2010,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Radioactive implants (includes brachytherapy) (1988+),HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,60 years,2,0,Counties in metropolitan areas ge 1 million pop
17,38,Female,2010,Alive at last contact,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8201,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8201/2: Cribriform carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,68 years,3,0,Counties in metropolitan areas ge 1 million pop
54,100,Female,2010,Alive at last contact,000,48,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Localized,64 years,2,0,Counties in metropolitan areas ge 1 million pop
62,119,Female,2010,2019,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,86 years,4,0,Counties in metropolitan areas ge 1 million pop
74,139,Female,2010,2010,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8010,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8010/3: Carcinoma, NOS","8010/3: Carcinoma, NOS",Blank(s),Left - origin of primary,Regional,63 years,2,0,Counties in metropolitan areas ge 1 million pop
91,179,Female,2010,2013,001,41,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8541,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8541/3: Paget disease and infiltrating ductal carcinoma of breast,8541/3: Paget disease and infiltrating ductal carcinoma of breast,Blank(s),Right - origin of primary,Regional,83 years,2,0,Counties in metropolitan areas ge 1 million pop
96,188,Female,2010,Alive at last contact,001,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Right - origin of primary,Regional,76 years,4,0,Counties in metropolitan areas ge 1 million pop
100,194,Female,2010,Alive at last contact,002,20,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,80 years,4,0,Counties in metropolitan areas ge 1 million pop
105,202,Female,2010,2020,001,40,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,90+ years,4,0,Counties in metropolitan areas ge 1 million pop
116,219,Female,2010,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Right - origin of primary,In situ,57 years,3,0,Counties in metropolitan areas ge 1 million pop
135,260,Female,2010,Alive at last contact,002,24,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,66 years,3,0,Counties in metropolitan areas ge 1 million pop
142,275,Female,2010,Alive at last contact,002,45,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,51 years,3,0,Counties in metropolitan areas ge 1 million pop
144,277,Female,2010,2019,001,20,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,83 years,2,0,Counties in metropolitan areas ge 1 million pop
148,281,Female,2010,Alive at last contact,001,44,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,70 years,2,0,Counties in metropolitan areas ge 1 million pop
151,292,Female,2010,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,73 years,4,0,Counties in metropolitan areas ge 1 million pop
165,328,Female,2010,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Regional,65 years,3,0,Counties in metropolitan areas ge 1 million pop
178,368,Female,2010,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,68 years,2,0,Counties in metropolitan areas ge 1 million pop
186,394,Female,2010,Alive at last contact,003,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Regional,70 years,2,0,Counties in metropolitan areas ge 1 million pop
189,406,Female,2010,2018,006,44,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,57 years,2,0,Counties in metropolitan areas ge 1 million pop
200,442,Female,2010,2010,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,90+ years,4,0,Counties in metropolitan areas ge 1 million pop
202,458,Female,2010,2010,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8010,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8010/3: Carcinoma, NOS","8010/3: Carcinoma, NOS",Blank(s),Left - origin of primary,Regional,73 years,2,0,Counties in metropolitan areas ge 1 million pop
204,469,Female,2010,Alive at last contact,002,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8522/2: Intraductal and lobular in situ carcinoma,In situ,Blank(s),Left - origin of primary,In situ,84 years,2,0,Counties in metropolitan areas ge 1 million pop
213,520,Female,2010,Alive at last contact,002,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,77 years,2,0,Counties in metropolitan areas ge 1 million pop
215,533,Female,2010,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Regional,62 years,2,0,Counties in metropolitan areas ge 1 million pop
216,537,Female,2010,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,61 years,3,0,Counties in metropolitan areas ge 1 million pop
221,544,Female,2010,Alive at last contact,001,51,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8530,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,8530/3: Inflammatory carcinoma,8530/3: Inflammatory carcinoma,Blank(s),Right - origin of primary,Regional,51 years,2,0,Counties in metropolitan areas ge 1 million pop
229,581,Female,2010,Alive at last contact,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Negative,Negative,Borderline/Unknown,In situ,In situ,Breast,8523,Undifferentiated; anaplastic; Grade IV,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,60 years,2,0,Counties in metropolitan areas ge 1 million pop
241,622,Female,2010,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,63 years,2,0,Counties in metropolitan areas ge 1 million pop
244,631,Female,2010,2014,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,72 years,3,0,Counties in metropolitan areas ge 1 million pop
265,697,Female,2010,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,61 years,2,0,Counties in metropolitan areas ge 1 million pop
269,707,Female,2010,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,66 years,4,0,Counties in metropolitan areas ge 1 million pop
270,712,Female,2010,Alive at last contact,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,81 years,2,0,Counties in metropolitan areas ge 1 million pop
274,725,Female,2010,Alive at last contact,000,20,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,58 years,2,0,Counties in metropolitan areas ge 1 million pop
303,803,Female,2010,2019,000,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,58 years,3,0,Counties in metropolitan areas ge 1 million pop
310,825,Female,2010,2015,001,41,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,63 years,5,0,Counties in metropolitan areas ge 1 million pop
311,826,Female,2010,2015,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8500,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Right - origin of primary,In situ,63 years,5,0,Counties in metropolitan areas ge 1 million pop
312,829,Female,2010,2013,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,57 years,4,0,Counties in metropolitan areas ge 1 million pop
313,830,Female,2010,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,"Radiation, NOS  method or source not specified",HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,74 years,2,0,Counties in metropolitan areas ge 1 million pop
316,837,Female,2010,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,78 years,2,0,Counties in metropolitan areas ge 1 million pop
318,840,Female,2010,Alive at last contact,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8230,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8230/2: Ductal carcinoma in situ, solid type",In situ,Blank(s),Left - origin of primary,In situ,80 years,2,0,Counties in metropolitan areas ge 1 million pop
327,868,Female,2010,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,"Radiation, NOS  method or source not specified",HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,60 years,3,0,Counties in metropolitan areas ge 1 million pop
329,874,Female,2010,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,46 years,2,0,Counties in metropolitan areas ge 1 million pop
331,876,Female,2010,Alive at last contact,000,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,68 years,3,0,Counties in metropolitan areas ge 1 million pop
337,886,Female,2010,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8201,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8201/2: Cribriform carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,64 years,3,0,Counties in metropolitan areas ge 1 million pop
351,931,Female,2010,2012,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,81 years,2,0,Counties in metropolitan areas ge 1 million pop
353,934,Female,2010,Alive at last contact,003,45,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Left - origin of primary,Localized,67 years,3,0,Counties in metropolitan areas ge 1 million pop
354,935,Female,2010,Alive at last contact,000,40,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8520,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8520/2: Lobular carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,67 years,3,0,Counties in metropolitan areas ge 1 million pop
360,956,Female,2010,2016,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,79 years,3,0,Counties in metropolitan areas ge 1 million pop
371,993,Female,2010,Alive at last contact,001,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,72 years,2,0,Counties in metropolitan areas ge 1 million pop
373,996,Female,2010,2012,003,41,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,61 years,2,0,Counties in metropolitan areas ge 1 million pop
378,1007,Female,2010,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,83 years,3,0,Counties in metropolitan areas ge 1 million pop
381,1013,Female,2010,2019,001,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8524,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8524/3: Infiltrating lobular mixed with other types of carcinoma,8524/3: Infiltrating lobular mixed with other types of carcinoma,Blank(s),Left - origin of primary,Localized,66 years,2,0,Counties in metropolitan areas ge 1 million pop
387,1020,Female,2010,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,85 years,3,0,Counties in metropolitan areas ge 1 million pop
388,1022,Female,2010,2018,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,90+ years,3,0,Counties in metropolitan areas ge 1 million pop
391,1034,Female,2010,Alive at last contact,001,59,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,76 years,2,0,Counties in metropolitan areas ge 1 million pop
407,1093,Female,2010,Alive at last contact,002,52,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Negative,Negative,Borderline/Unknown,In situ,In situ,Breast,8523,Undifferentiated; anaplastic; Grade IV,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,64 years,3,0,Counties in metropolitan areas ge 1 million pop
422,1128,Female,2010,Alive at last contact,000,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Regional,58 years,3,0,Counties in metropolitan areas ge 1 million pop
453,1205,Female,2010,2010,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,90+ years,3,0,Counties in metropolitan areas ge 1 million pop
460,1219,Female,2010,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Left - origin of primary,Localized,66 years,2,0,Counties in metropolitan areas ge 1 million pop
467,1237,Female,2010,2013,005,24,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,77 years,2,0,Counties in metropolitan areas ge 1 million pop
477,1296,Female,2010,Alive at last contact,001,40,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,72 years,2,0,Counties in metropolitan areas ge 1 million pop
496,1339,Female,2010,2016,001,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,82 years,7,0,Counties in metropolitan areas ge 1 million pop
497,1346,Female,2010,Alive at last contact,003,22,Intraoperative radiation,Systemic therapy after surgery,Surgery performed,No/Unknown,Radioactive implants (includes brachytherapy) (1988+),HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,60 years,2,0,Counties in metropolitan areas ge 1 million pop
499,1350,Female,2010,2012,001,0,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Not recommended,Yes,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Distant,54 years,2,0,Counties in metropolitan areas ge 1 million pop
519,1404,Female,2010,2017,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8140,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8140/3: Adenocarcinoma, NOS","8140/3: Adenocarcinoma, NOS",Blank(s),"Paired site, but no information concerning laterality",Distant,59 years,3,0,Counties in metropolitan areas ge 1 million pop
527,1428,Female,2010,2019,003,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Negative,Negative,Borderline/Unknown,In situ,In situ,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,73 years,2,0,Counties in metropolitan areas ge 1 million pop
533,1442,Female,2010,Alive at last contact,000,24,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,65 years,3,0,Counties in metropolitan areas ge 1 million pop
536,1454,Female,2010,2012,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,"Not recommended, contraindicated due to other cond; autopsy only (1973-2002)",No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8140,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8140/3: Adenocarcinoma, NOS","8140/3: Adenocarcinoma, NOS",Blank(s),Left - origin of primary,Localized,85 years,2,0,Counties in metropolitan areas ge 1 million pop
573,1557,Female,2010,2011,000,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,90+ years,3,0,Counties in metropolitan areas ge 1 million pop
574,1559,Female,2010,Alive at last contact,002,22,Radiation after surgery,Systemic therapy before surgery,Surgery performed,Yes,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,55 years,2,0,Counties in metropolitan areas ge 1 million pop
600,1628,Female,2010,Alive at last contact,001,42,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Left - origin of primary,Localized,76 years,3,0,Counties in metropolitan areas ge 1 million pop
601,1629,Female,2010,Alive at last contact,000,0,Radiation after surgery,Systemic therapy after surgery,Not recommended,No/Unknown,Beam radiation,Unknown,Borderline/Unknown,Borderline/Unknown,Negative,Malignant,Malignant,Breast,8522,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Regional,76 years,3,0,Counties in metropolitan areas ge 1 million pop
620,1678,Female,2010,Alive at last contact,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8230,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8230/2: Ductal carcinoma in situ, solid type",In situ,Blank(s),Left - origin of primary,In situ,87 years,2,0,Counties in metropolitan areas ge 1 million pop
634,1712,Female,2010,Alive at last contact,002,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,67 years,2,0,Counties in metropolitan areas ge 1 million pop
640,1732,Female,2010,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,78 years,4,0,Counties in metropolitan areas ge 1 million pop
643,1741,Female,2010,Alive at last contact,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8201,Undifferentiated; anaplastic; Grade IV,Blank(s),Blank(s),Not classified by SEER or in situ,8201/2: Cribriform carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,72 years,3,0,Counties in metropolitan areas ge 1 million pop
648,1756,Female,2010,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Right - origin of primary,In situ,61 years,4,0,Counties in metropolitan areas ge 1 million pop
655,1772,Female,2010,Alive at last contact,002,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Undifferentiated; anaplastic; Grade IV,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Right - origin of primary,In situ,80 years,4,0,Counties in metropolitan areas ge 1 million pop
669,1829,Female,2010,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,56 years,4,0,Counties in metropolitan areas ge 1 million pop
670,1830,Female,2010,Alive at last contact,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,56 years,4,0,Counties in metropolitan areas ge 1 million pop
671,1831,Female,2010,2018,002,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,89 years,2,0,Counties in metropolitan areas ge 1 million pop
675,1851,Female,2010,Alive at last contact,001,42,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,64 years,3,0,Counties in metropolitan areas ge 1 million pop
685,1880,Female,2010,Alive at last contact,Blank(s),41,No radiation and/or cancer-directed surgery,Systemic therapy both before and after surgery,Surgery performed,Yes,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,64 years,2,0,Counties in metropolitan areas ge 1 million pop
686,1881,Female,2010,Alive at last contact,002,45,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Negative,Borderline/Unknown,In situ,In situ,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,71 years,2,0,Counties in metropolitan areas ge 1 million pop
692,1895,Female,2010,2011,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,84 years,4,0,Counties in metropolitan areas ge 1 million pop
695,1899,Female,2010,Alive at last contact,000,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Negative,Negative,Borderline/Unknown,In situ,In situ,Breast,8523,Poorly differentiated; Grade III,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,76 years,2,0,Counties in metropolitan areas ge 1 million pop
697,1902,Female,2010,Alive at last contact,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,64 years,2,0,Counties in metropolitan areas ge 1 million pop
704,1924,Female,2010,2013,000,22,Radiation after surgery,Systemic therapy before surgery,Surgery performed,Yes,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,70 years,2,0,Counties in metropolitan areas ge 1 million pop
709,1934,Female,2010,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,56 years,2,0,Counties in metropolitan areas ge 1 million pop
721,1959,Female,2010,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,77 years,2,0,Counties in metropolitan areas ge 1 million pop
723,1962,Female,2010,Alive at last contact,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,65 years,2,0,Counties in metropolitan areas ge 1 million pop
749,2020,Female,2010,Alive at last contact,001,40,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,"8500/2: Intraductal carcinoma, noninfiltrating, NOS",In situ,Blank(s),Left - origin of primary,In situ,78 years,2,0,Counties in metropolitan areas ge 1 million pop
756,2032,Female,2010,2012,000,0,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8140,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8140/3: Adenocarcinoma, NOS","8140/3: Adenocarcinoma, NOS",Blank(s),Right - origin of primary,Distant,71 years,2,0,Counties in metropolitan areas ge 1 million pop
757,2038,Female,2010,Alive at last contact,002,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,61 years,2,0,Counties in metropolitan areas ge 1 million pop
769,2065,Female,2010,2017,002,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,75 years,2,0,Counties in metropolitan areas ge 1 million pop
773,2072,Female,2010,2020,Blank(s),0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8522,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Regional,53 years,5,0,Counties in metropolitan areas ge 1 million pop
777,2079,Female,2010,Alive at last contact,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,85 years,2,0,Counties in metropolitan areas ge 1 million pop
780,2084,Female,2010,2014,001,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
786,2099,Female,2010,Alive at last contact,001,22,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Left - origin of primary,Localized,71 years,2,0,Counties in metropolitan areas ge 1 million pop
795,2123,Female,2010,2017,001,0,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Not recommended,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Distant,69 years,3,0,Counties in metropolitan areas ge 1 million pop
805,2144,Female,2010,Alive at last contact,001,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,76 years,6,0,Counties in metropolitan areas ge 1 million pop
806,2145,Female,2010,Alive at last contact,001,23,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,76 years,6,0,Counties in metropolitan areas ge 1 million pop
808,2148,Female,2010,2012,000,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,65 years,3,0,Counties in metropolitan areas ge 1 million pop
810,2153,Female,2010,Alive at last contact,001,48,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,HR-/HER2-,Negative,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,57 years,2,0,Counties in metropolitan areas ge 1 million pop
812,2157,Female,2010,2015,003,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2+,Positive,Positive,Positive,Malignant,Malignant,Breast,8507,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8507/3: Ductal carcinoma, micropapillary","8507/3: Ductal carcinoma, micropapillary",Blank(s),Right - origin of primary,Regional,89 years,2,0,Counties in metropolitan areas ge 1 million pop
813,2166,Female,2010,Alive at last contact,004,22,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8520,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8520/2: Lobular carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,58 years,2,0,Counties in metropolitan areas ge 1 million pop
845,2266,Female,2010,Alive at last contact,001,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,64 years,2,0,Counties in metropolitan areas ge 1 million pop
851,2289,Female,2010,2019,001,20,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,78 years,2,0,Counties in metropolitan areas ge 1 million pop
859,2307,Female,2010,Alive at last contact,002,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,78 years,2,0,Counties in metropolitan areas ge 1 million pop
864,2322,Female,2010,Alive at last contact,000,22,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Left - origin of primary,In situ,58 years,5,0,Counties in metropolitan areas ge 1 million pop
865,2323,Female,2010,Alive at last contact,000,55,No radiation and/or cancer-directed surgery,Systemic therapy before surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8522,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,8522/3: Infiltrating duct and lobular carcinoma,8522/3: Infiltrating duct and lobular carcinoma,Blank(s),Right - origin of primary,Localized,59 years,5,0,Counties in metropolitan areas ge 1 million pop
869,2330,Female,2010,2013,001,52,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,83 years,2,0,Counties in metropolitan areas ge 1 million pop
880,2357,Female,2010,2014,000,51,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,Yes,None/Unknown,Unknown,Negative,Borderline/Unknown,Borderline/Unknown,Malignant,Malignant,Breast,8010,Unknown,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8010/3: Carcinoma, NOS","8010/3: Carcinoma, NOS",Blank(s),Right - origin of primary,Regional,63 years,2,0,Counties in metropolitan areas ge 1 million pop
881,2358,Female,2010,Alive at last contact,001,40,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Negative,Negative,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,67 years,3,0,Counties in metropolitan areas ge 1 million pop
886,2364,Female,2010,Alive at last contact,001,20,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Borderline/Unknown,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,64 years,2,0,Counties in metropolitan areas ge 1 million pop
889,2373,Female,2010,Alive at last contact,000,51,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,43 years,2,0,Counties in metropolitan areas ge 1 million pop
890,2378,Female,2010,Alive at last contact,000,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Regional,71 years,3,0,Counties in metropolitan areas ge 1 million pop
900,2392,Female,2010,2014,000,40,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,Unknown,Borderline/Unknown,Borderline/Unknown,Borderline/Unknown,In situ,In situ,Breast,8504,Unknown,Blank(s),Blank(s),Not classified by SEER or in situ,8504/2: Noninfiltrating intracystic carcinoma,In situ,Blank(s),Right - origin of primary,In situ,86 years,2,0,Counties in metropolitan areas ge 1 million pop
920,2432,Female,2010,2014,001,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,85 years,4,0,Counties in metropolitan areas ge 1 million pop
926,2440,Female,2010,2011,001,41,No radiation and/or cancer-directed surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,90+ years,2,0,Counties in metropolitan areas ge 1 million pop
942,2483,Female,2010,Alive at last contact,001,23,Radiation after surgery,No systemic therapy and/or surgical procedures,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8520,Moderately differentiated; Grade II,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8520/3: Lobular carcinoma, NOS","8520/3: Lobular carcinoma, NOS",Blank(s),Right - origin of primary,Localized,81 years,3,0,Counties in metropolitan areas ge 1 million pop
956,2517,Female,2010,2019,002,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Left - origin of primary,Localized,74 years,5,0,Counties in metropolitan areas ge 1 million pop
957,2518,Female,2010,2019,002,41,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,Unknown,Positive,Positive,Borderline/Unknown,In situ,In situ,Breast,8523,Moderately differentiated; Grade II,Blank(s),Blank(s),Not classified by SEER or in situ,8523/2: Intraductal with other types of carcinoma in situ,In situ,Blank(s),Right - origin of primary,In situ,74 years,5,0,Counties in metropolitan areas ge 1 million pop
970,2556,Female,2010,2014,001,41,Radiation after surgery,Systemic therapy after surgery,Surgery performed,Yes,Beam radiation,HR-/HER2+,Negative,Negative,Positive,Malignant,Malignant,Breast,8500,Poorly differentiated; Grade III,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Regional,68 years,2,0,Counties in metropolitan areas ge 1 million pop
980,2586,Female,2010,2011,001,22,Radiation after surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,Beam radiation,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8523,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,8523/3: Infiltrating duct mixed with other types of carcinoma,8523/3: Infiltrating duct mixed with other types of carcinoma,Blank(s),Right - origin of primary,Regional,81 years,2,0,Counties in metropolitan areas ge 1 million pop
990,2608,Female,2010,2016,002,43,No radiation and/or cancer-directed surgery,Systemic therapy after surgery,Surgery performed,No/Unknown,None/Unknown,HR+/HER2-,Positive,Positive,Negative,Malignant,Malignant,Breast,8500,Well differentiated; Grade I,Blank(s),Blank(s),XIf6 Carcinomas of breast,"8500/3: Infiltrating duct carcinoma, NOS","8500/3: Infiltrating duct carcinoma, NOS",Blank(s),Right - origin of primary,Localized,70 years,4,0,Counties in metropolitan areas ge 1 million pop
